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Zusammenfassung
Niedermolekulare Naturstoffe aus Bakterien, Pilzen, Pflanzen und marinen
Organismen weisen eine einzigartige strukturelle Diversität auf, die für die
Identifizierung neuer Leitstrukturen für die Entwicklung von Arzneistoffen und
Pflanzenschutzmitteln von großer Bedeutung ist. Im Rahmen der Suche nach
bioaktiven Verbindungen aus marinen Schwämmen und mit diesen Schwämmen
assoziierten Pilzen wurden in dieser Arbeit insgesamt 26 Sekundärstoffe isoliert,
wobei es sich bei acht Substanzen um neue Verbindungen handelt. Die Schwämme
wurden im indo-pazifischen Gebiet gesammelt, insbesondere aus Indonesien und
den Philippinen, so wie aus dem Mittelmeer in der Nähe der Insel Elba in Italien. Für
die Entdeckung neuer bioaktiver Substanzen wurde eine Kombination von
chemischen und biologischen Methoden angewendet, wodurch Extrakte mit
verschiedenen Screening-Methoden auf Bioaktivität getestet worden sind. Zum
Einsatz kamen dabei Versuche mit Raupen des polyphagen Nachtfalters Spodoptera
littoralis (Noctuidae; Lepidoptera) im Hinblick auf potentielle insektizide Wirkungen,
antimikrobielle Untersuchungen mit gram-negativen und gram-positiven Bakterien
und dem Pilz Candida albicans, Zytotoxizitätstests gegenüber menschlichen
Krebszellen und Toxizitätstests mit dem Krebs Artemia salina. Zusätzlich zur
bioaktivitäts-geleiteten Isolierung von Substanzen aus aktiven Extrakten wurden
daneben auch DC, UV und MS als Kriterien herangezogen, um die aus chemischer
Sicht interessantesten Verbindungen zu isolieren. Damit konnten auch solche
Substanzen, die nicht für die Aktivität der Extrakte im Bioscreening verantwortlich
waren, weiteren Biotests unterzogen werden.
Im einzelnen wurden die folgenden Verbindungen isoliert, ihre Struktur aufgeklärt,
und ihre biologische Aktivität näher charakterisiert:
1. Der antimikrobiell aktive Extrakt aus dem Pilz Cladosporium herbarum, der mit
dem indonesischen Schwamm Callyspongia aerizusa assoziiert ist, ergab sieben
Polyketide, die strukturell ähnlich sind, einschließlich der beiden neuen zwölf-
gliedrigen Makrolide Pandangolid 3 und Pandangolid 4, sowie ein neues
acetyliertes Derivat des bereits bekannten Naturstoffs 5-Hyroxymethyl-2-
furancarbonsäure. Beide Furancarbonsäuren zeigten antimikrobielle Aktivität und
xiii
dürften deshalb hauptsächlich für die antimikrobielle Aktivität des Extrakts
verantwortlich sein.
Daß Cladospolid B, ein bekanntes Phytotoxin, das bereits für die Arten
Cladosporium cladosporoiodes und C. tenuissimum beschrieben wurde, ebenfalls
aus C. herbarum isoliert wurde, deutet darauf hin, daß Cladospolid B als ein
chemotaxonomischer Marker für bestimmte Cladosporium-Arten angesehen
werden könnte. 
2. Der antimikrobiell aktive Extrakt aus dem Pilz Curvularia lunata, der mit dem
indonesischen Schwamm Niphates olemda assoziiert ist, ergab drei Substanzen,
nämlich das neue antimikrobiell aktive Anthrachinon Lunatin sowie das bereits
bekannte Bisanthrachinon Cytoskyrin A, und das bekannte Pflanzenhormon
Abscisinsäure. Das gemeinsame Vorkommen der beiden strukturell verwandten
Anthranoide könnte ein Indiz dafür sein, daß das Monomer Lunatin eine
biogenetische Vorstufe des Bisanthrachinons Cytoskyrin A darstellt.
3. Ein mit dem im Mittelmeer gesammelten Schwamm Axinella verrucosa
assoziierter Pilz der Gattung Penicillium ergab insgesamt sechs Substanzen, im
einzelnen das bekannte Antimykotikum Griseofulvin und dessen weniger aktives
Dechlor-Derivat, das bekannte Toxin Oxalin, sowie die als zytotoxisch
beschriebene Verbindung Communesin B und deren neue Derivate Communesin
C und Communesin D. Im Vergleich zu Communesin B erwiesen sich die neuen
Communesin-Derivate als weniger aktiv gegenüber dem Krebs A. salina. 
4. Ein bisher unidentifizierter Pilz aus dem gleichen Schwamm Axinella verrucosa
lieferte die bekannte Substanz Monocerin, über deren phytotoxische und
insektizide Eigenschaften bereits berichtet wurde.
5. Der mit dem philippinischen Schwamm Hyrtios aff. reticulatus assoziierte Pilz
Aspergillus flavus ergab das bereits bekannte Toxin α-Cyclopiazonsäure.
6. Der indonesische Schwamm Agelas nakamurai lieferte vier bromierte Pyrrol-
Alkaloide, nämlich die neue Substanz 4-Brompyrrol-2-carbonsäure sowie die
bereits bekannten Verbindungen 4-Brompyrrol-2-carboxamid, Mukanadin B und
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Mukanadin C. Alle vier Substanzen außer Mukanadin B zeigten antimikrobielle
Aktivität. Bromierte Pyrrol-Alkaloide wurden in vielen Untersuchungen als typische
Sekundärstoffe der Schwammgattung Agelas beschrieben, die bei der
chemischen Verteidigung der Schwämme gegen Fische eine wichtige Rolle
spielen.
             
7. Der indonesiche Schwamm Jaspis splendens ergab drei bekannte Substanzen,
die für ihre antiproliferative Aktivität bekannt sind, nämlich die Depsipeptide
Jaspamid (Jasplakinolid) und dessen Derivate Jaspamid B und Jaspamid C.
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I. Introduction
1.1. Significance of the study
1.1.1. The need for lead compounds for drug development
Even today, after more than 100 years of research in pharmaceutical industries,
there is still a great need for innovative drugs. Only one third of all diseases can be
treated efficiently [Müller et al., 2000]. This means that there is a need for new drug
entities to enable therapeutic innovations.
The economic importance of natural products is evident in a conference entitled
Profiting from biodiversity by leveraging natural product discovery, which took place
on 28-29 June 1999 in London. It was highlighted that ten of the top 20 selling
medicines in 1998 were derived from natural products [Lawrence, 1999]. It was also
claimed that drugs derived from natural products acquire a market share of about 80
billion US $ in the world pharmaceutical market [Müller et al., 2000]. Furthermore, a
study using US-based prescription data from 1993 showed that over 50% of the
most-prescribed drugs in the US had a natural product either as the drug, or as a
‘forebear’ in the synthesis or design of the agent [Grifo et al., 1997], thus
demonstrating that natural products still play a major role in drug treatment.
The role of natural products in drug discovery is demonstrated by an analysis of the
number and sources of anticancer and antiinfective agents, reported mainly in the
Annual Reports of Medicinal Chemistry from 1984 to 1995 [Cragg, 1997]. It was
observed that over 60% of the approved drugs and pre-NDA (New Drug Applications)
candidates (for the period 1989-1995), excluding biologics (vaccines, monocloneals,
etc. derived from mammalian sources), developed in these disease areas are of
natural origin. 
Drugs of natural origin have been classified as original natural products, products
derived semisynthetically from natural products, or synthetic products based on
natural product models [Cragg, 1997]. Bioactive natural products could thus serve as
Introduction
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lead structures which could then be ‘optimized’ through classical medicinal chemistry
techniques and the more recent combinatorial synthesis methods to come up with
new agents with improved pharmacokinetics and/or toxicology (Fig. 1.1).
Natural products/Extracts
                   Synthetics         Combinatorial Chemistry
        Lead Structure
  Development Candidate
                Drug
Fig. 1.1: Sources of compounds for drug discovery.
A lead compound is a compound with many of the characteristics of a desired new
drug which will be used as a model for chemical modification. It must be potent, but it
does not need to possess the potency at the nanomolar or picomolar levels expected
of a product candidate. It must be specific for the desired target, but it does not need
to possess the exquisite biochemical specificity required for a new drug. Finally, it
must be available in sufficient quantities to support the early stages of development,
such as biological characterization and toxicity studies, while a total synthesis of the
product candidates is being completed.
Low-molecular mass natural products from bacteria, fungi, plants and marine
organisms exhibit unique structural diversity, and are of maximum interest for
identifying new lead structures. Thomas Henkel (Bayer AG, Wuppertal, Germany)
reported that most natural products have a higher molecular weight than their
synthetic counterparts, containing more rings and being generally more sterically
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complex [Lawrence, 1999]. Furthermore, Henkel found that, on comparison of the
compounds in a natural product datase (DNP) with a representative pool of chemical
test substances (Synthetics), there was only a 60% homology. Henkel also
demonstrated that by comparing the structures of natural products, synthetic drugs,
and currently used drugs, there was a much higher incidence of O-containing groups
in the natural product compounds. Furthermore, natural product compounds were
found to contain more sp3-hybridized bridgehead atoms. This illustrates the diverse
range of compounds that can be gained from natural products that would otherwise
be missed using synthetic techniques. 
1.1.2. Strategies for drug development from natural products
Generally, strategies for drug discovery can be separated into three categories:
chemically driven, biologically driven and a combination of both [McConnell et al.,
1994]. In the chemically driven or ‘traditional grind-and find’ approach, which has
been pursued mainly by academic research groups, the object of the search was to
find novel compounds from marine sources. Hence, extracts are ‘screened’ by TLC,
1H and 13C NMR for unusual and interesting patterns. The next step for this approach
is then finding biological properties for purified compounds. The biologically driven
strategy is the bioassay-guided approach beginning with crude extracts and has
been the preferred method by modern marine natural product researchers. 
The biologically driven approach which involves ‘screening’ crude extracts for
biological activity, followed by the crucial work of backtracking the active compounds
from the ‘hit’-extracts dominate natural products research up to the present.
However, a lot of experience is required to exclude both false positive and false
negative results. Considerable effort is required to get access to sufficient quantities
of raw material for reproduction, isolation, structure elucidation and subsequent
verification of biological activity. The complete process proved to be highly time and
capacity consuming. Moreover, false positives may result when the activity shown by
an extract is attributed to a synergistic effect of more than one constituent in the
extract.
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It seems advantageous to perform a screening with pure compounds rather than with
crude extracts. For individuals, however, the problem arises of getting access to
sufficient numbers of natural compounds covering a substantial structural diversity. A
new approach utilized by pharmaceutical industries for the discovery of new drugs is
the creation of a central natural product pool. With a natural product pool, supplied by
the industry and the academic institutions, compounds are getting a more realistic
chance to be discovered and highlighted in diverse target directed bioassay systems
of therapeutic value.  Together with high thoroughput screening (HTS), a greater
number of ‘hits’ of lead compounds have been identified.
The development of new bioassay methods that can selectively detect biologically
active molecules at very low levels as well as the advances in chemical
instrumentation (e.g. high performance liquid chromatography (HPLC), high
performance centrifugal countercurrent chromatography (HPCCC), capillary zone
electrophoresis (CZE), high resolution mass spectrometry (HRMS), high field nuclear
magnetic resonance (NMR) and X-ray crystallography which now allow the chemist
to isolate submilligram quantities of the new compounds, and confidently be able to
fully characterize them and identify their structures contributed to the current peak in
interest in natural products.
New bioassays which target receptors and enzymes involved in pathogenesis of
disease are being developed. These assays reflect new opportunities due to the
recent identification of previously unrecognized biomolecular targets for therapy. 
1.2. Current status of marine natural product research
Although natural products research was previously focused mainly on plants, growing
interests in marine natural products have led to the discovery of an increasing
number of potently active agents considered worthy for clinical application. The
world’s oceans cover more than 70% of the earth’s surface represent our greatest
resource of new natural products [McConnell et al., 1994]. The sea contains well over
200,000 invertebrate and algal species [Ibid]. There exist nearly 150,000 species of
algae (sea weed): green (Chlorophyta), red (Rhodophyta), and brown (Phaeophyta),
and some groups of marine invertebrates in which new chemical structures or
Introduction
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biological activities have been reported: sponges (Porifera), cnidarians or
coelenterates [corals, octocorals (including sea fans), hydroids, and sea anemones],
nemerteans (worms), bryozoans, ascidians (tunicates including sea squirts), molluscs
(sea snails and sea slugs), and echinoderms (brittlestars, sea urchins, starfish, and
sea cucumbers) [Ibid]. 
The earliest findings include the arabinose-nucleosides, known since the 1950’s as
constituents of the Carribean sponge Cryptotethya crypta (Tethydae) which served
as lead compounds for the synthesis of analogues, ara-A (Vidarabin, Vidarabin
Thilo) and ara-C (Cytarabin, Alexan, Udicil) with improved antiviral and anticancer
activity. Since then however, the systematic investigation of marine environments as
sources of novel biolgically active agents only began in earnest in the mid-1970s.
During the decade from 1977-1987, about 2500 new metabolites were reported from
a variety of marine organisms [Newman et al., 2000]. Prior to 1995, a total of 6500
marine natural products had been isolated; by January of 1999, this figure had risen
to approximately 10,000 [Jaspars, 1999]. These studies have clearly demonstrated
that the marine environment is a rich source of bioactive compounds, many of which
belong to totally novel chemical classes not found in terrestrial sources.
A recent review provided an updated list of marine natural products which are
currently under clinical trials (Table 1) (Fig. 1.2) [Proksch et al., 2002]. 
Introduction
6
Table 1.1: Selected natural products from marine sources which are currently
undergoing clinical trials.* 
Source Compounds Disease area
Phase
of
clinical
trial
Conus magnus
(cone snail)
Ziconotide Pain III
Ecteinascidia
turbinata (tunicate)
Ecteinascidin
743
Cancer II/III
Dolabella auricularia
(sea hare)
Dolastatin 10 Cancer II
Dolabella auricularia
(sea hare)
LU103793a Cancer II
Bugula neritina
(bryozoan)
Bryostatin 1 Cancer II
Trididemnum
solidum (tunicate)
Didemnin B Cancer II
Squalus acanthias
(shark)
Squalamine
lactate
Cancer II
Aplidium albicans
(tunicate)
Aplidine Cancer I/II
Agelas mauritianus
(sponge)
KRN7000b Cancer I
Petrosia contignata
(sponge)
IPL 576,092c Inflammation/
asthma
I
Pseudopterogorgia
elisabethae (soft
coral)
Methopterosind Inflammation/
wound
I
Luffariella variabilis
(sponge)
Manoalide Inflammation/
psoriasis
I
Amphiporus
lactifloreus (marine
worm)
GTS-21c Alzheimer/
schizophrenia
I
*reproduced from Proksch et al 2002.
asynthetic analogue of dolastatin 15
bAgelasphin analogue (α-galactosylceramide derivative)
csynthetic analogue of contignasterol (IZP-94,005)
dsemisynthetic pseudopterosin derivative
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Fig. 1.2: Selected natural products currently undergoing clinical trials
Introduction
8
1.3. Role of metabolites in host organisms
Another point of interest for marine natural product researchers is the natural function
of the metabolites that they study. It has been observed that the majority of bioactive
marine natural products have been isolated from soft-bodied, sessile or slow-moving
marine invertebrates that are usually devoid of morphological defense structures
such as spines or protective shells. This points out the ecological importance of these
metabolites for the respective invertebrates and is corroborated by numerous studies
which relate the accumulation of toxic natural products with their role as chemical
defense to fight off potential predators (e.g. fishes) [Pawlik et al., 1995; Chanas et al.,
2996; Wilson et al., 1999; Lindel et al., 2000] or to force back neighbors competing
for space [Proksch and Ebel, 1998; Proksch, 1999; McClintock, 2001]. These include
studies of the feeding deterrence caused by algal metabolites and the production of
metabolites by sessile organisms which inhibit settling of fouling organisms [Faulkner,
2000]. Furthermore, the observation that many nudibranchs sequestered metabolites
of sponges and tunicates have led to the hypothesis that these shell-less molluscs
had evolved by loss of their shell after the ancestral mollusc had acquired defense
chemicals of dietary origin [Faulkner, 1983].
A study of the chemical diversity within organisms of the same species suggests that
biosynthesis of secondary metabolites may be influenced by various external factors
such as prevailing environmental conditions, e.g., presence of predators, infection
with parasites, water temperature, depth, and nutrient levels. Internal factors, eg.,
stage of development/reproduction and chemical races may also play a role as well
as the presence and type of symbionts within or on the tissues of a host organism.
The presence of symbionts like bacteria [Hamel et al., 1995], cyanobacteria [Rützler,
1990], and to a lesser extent dinophycean zooxanthellae and eucaryotic algae in
sponge tissue is well documented [Ibid]. Furthermore, the result of a number of
studies seems to point out that the symbionts are the true producers of the
secondary metabolites isolated from marine invertebrates. Numerous examples have
been cited in a review [Moore, 1999] wherein structurally related or identical
compounds have been reported from taxonomically distinct invertebrates or from
invertebrates and cultured microorganisms alike. A more conclusive evidence has
Introduction
9
been given by Faulkner and co-workers when they demonstrated in several cases
that secondary metabolites are cellularly located within sponge-associated
microorganisms [Faulkner et al., 1993; Bewley et al., 1998]. For instance, two
metabolites of the lithistid sponge Theonella swinhoei, swinholide A and the cyclic
peptide theopalauamide, were shown to be localized in a mixed bacterial fraction and
a filamentous δ-proteobacterium, respectively [Bewley et al., 1996]. This evidence,
however, operates under the assumption that the secondary metabolites are
biosynthesized within the cells in which they are localized and the possibility of an
exchange of biosynthetic precursors between the partners does not exist. 
Some authors consider fungi as symbionts of marine invertebrates [Müller et al.,
1981]. However, while fungal colonies have clearly been documented on the surface
of marine algae and sea grasses, there is a need to demonstrate that fungi grow
within sponges and other invertebrates [Faulkner et al., 2000]. Because of the
isolation from marine-derived fungi of secondary metabolites which have been
identified from terrestrial fungi in previous examinations, there is some doubt whether
some of these fungi are truly marine and whether they are epibionts, symbionts,
pathogens, or merely accidentally present in or on the studied materials. In certain
cases, particularly lignicolous and parasitic species, the answer is clear cut: they
belong to genera unknown onland and sporulate in sea water. In other cases,
typically for isolates from marine invertebrates, the answer is difficult for fungi that
belong to genera well known from land, particularly when the literature fails to
describe if they can sporulate in sea water. Terrestrial fungi are present in the oceans
and thus, represents a major problem when trying to obtain the slow-growing marine
fungi [Schaumann, 1974; Miller and Whitney, 1981]. 
1.4. Marine fungi as source of bioactive metabolites
The increasing number of secondary metabolites isolated from marine-derived fungi
[Faulkner, 2001; Faulkner 2002] prove that they are a rich source of bioactive
compounds with therapeutic potential. Natural product research using marine-derived
fungi is a relatively new field. In the 1940’s, the fungus Cephalosporium sp. was
isolated from the microbial flora of sea water collected from Cagliari, Italy.
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Subsequent chemical and biological investigation of this fungus led to the discovery
of the cephalosporins, now widely used in antibiotic therapy. 
Marine fungi are not a taxonomically-systematically, but an ecologically-
physiologically defined group of fungi (Mycophyta). They grow facultatively or
obligately in oceans and ocean-associated estuarine habitats that contain brackish
water including river mouths, tidal creeks and marshes, salinas, lagoons, and the
like.  The relatively narrow definition which is generally accepted is that obligate
marine fungi are those growing and sporulating exclusively in a marine and estuarine
habitat; facultative marine fungi are those isolated from marine environments but can
also grow under terrestrial conditions [Kohlenmeyer and Kohlenmeyer, 1979]. Marine
fungi that do not germinate in the natural marine habitat are not included in this
definition. A survey showed that a total of 321 species of marine mycelial fungi have
been recognized, representing 255 Ascomycetes, 60 Basidiomycetes, and 60
anamorphic (‘imperfect’) fungi (Deuteromycetes) [Kohlenmeyer and Volkmann-
Kohlenmeyer, 1991]. This number is continuously increasing by the discovery and
description of new species. Including the non-active marine fungi, the number of
mycel forming higher marine fungi is estimated to be at least 6000 [Schaumann et
al., 1993]. 
Many marine fungi are geographically widely distributed and appear to occur in all
climates and all salinities, but are often uniquely adapted for life in the sea. They live
as saprobes on algae, driftwood, decaying leaves and other dead organic material of
plant and animal origin. They may also occur as parasites on mangroves, shells,
crabs, sponges or in the gastrointestinal tract of fishes and are an important group of
pathogens in the marine world. Other species exist as symbionts in lichenoid
associations with algae on coastal cliffs. A vast number of less investigated fungal
species populate the deep sea and the seafloor. Some Endomycetes freely float as
plankton. Marine fungi represent a considerable amount of biomass in the marine
habitat. They live on high energy organic substances from carbon sources that are
taken up from their environment and decomposed into smaller molecules by specific
ecto- and exoenzymes. Among other substrates, marine fungi decompose cellulose,
lignine or alginate. They considerably contribute to the turnover of material and
energy of their environment and are used themselves as source of food by other
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marine organisms [Schaumann, 1974]. For ensuring their survival in their competition
with other organisms, marine fungi are compellingly dependent on the production of
secondary metabolites. This has been proven by the increasing number of
substances isolated from marine fungi with antibacterial, antifungal, and cytotoxic
activities [Faulkner 2001; Faulkner 2002]. About 70-80% of the secondary
metabolites that have been isolated from marine fungi are biologically active. 
It is interesting to note that fungi of the same species have been reported to yield
different types of metabolites. The lignicolous fungi Leptosphaeria oraemaris
(Pleosporaceae) yielded in one study Leptosphaerin (1) (Fig. 1.3) [Schiehser et al.,
1986; Pallenberg et al., 1986]. A further study of L. oraemaris, undertaken by the
group of Pietra, yielded none of the previously found metabolites, but the polyketides,
leptosphaerolide (2), it’s o-dihydroquinone derivative (3) and leptosphaerodione (4)
(Fig. 1.3) [Guerriero et al., 1991]. This leads to the conclusion that the production of
secondary metabolites might be highly dependent on the culture conditions and the
origin of the strains.  To produce these metabolites and to maximize the potential
chemical diversity, they need to be grown in various nutrient-limited media. For
example, media for Penicillium spp. that are deficient in C have been used to
produce penicillins, those that are P-limited produce cephalosphorins and
vancomycin, and those that are N-limited can produce carbapenems [Lawrence et
al., 1999].
It is still questionable whether marine natural products will play a major role in drug
discovery in the future as no unique secondary metabolite has yet been isolated
[Grabbley et al., 2000]. This is due in part to the predominant isolation and cultivation
of ubiquitous fungi even from samples collected in the marine environment. Today,
toxic principles dominate the spectrum of biological activities in products isolated
from marine sources. This maybe due to the major application of cytotoxicity-directed
screening assays. However, it has to be considered that defense strategies are
necessary to survive in the highly competitive marine environment, thus resulting a
tremendous diversity of highly toxic compounds affecting targets that are involved in
eukaryotic cell-signaling processes. The strong toxic properties of marine metabolites
often preclude their application in medicine. On the other hand, a number of
metabolites have proven to be valuable tools in biochemistry and cell and molecular
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biology. For example, the water-soluble polyether type neurotoxin, maitotoxin,
produced by the marine dinoflagellate Gambierdiscus toxicus heads the list of non-
peptide toxins and is being used as a unique pharmaceutical tool for studying
calcium transport [Murata and Yasumoto, 2000]. Currently, various other marine
natural products that exhibit considerable toxic potency are hopeful candidates for
clinical use, mainly in anticancer therapy. 
1.5. Statement of the objective
Since marine fungi represent a rich source of bioactive metabolites which have not
yet been fully exploited, this study is focused on these organisms. Organisms from
the Pacific basin, mostly collected around Okinawa, account for half of all species in
marine natural product patent applications; while the northwestern Atlantic accounts
for about a third of the species – mostly collected in the Bahamas and the Carribean.
The rest come from the Indian Ocean, the Red Sea and the Mediterranean
[Bongiorni, and Pietra, 1996]. These data should not be taken as a direct indication of
the most profitable areas for industrially exploitable waters but may be due to logistic
and jurisdictional opportunities. The greatest biodiversity have been known to be
supplied by organisms from tropical and sub-tropical waters. This study utilizes
marine fungi from diverse sources: the Indo-pacific regions particularly those from
Indonesian and Philippine waters, as well as those from the Mediterranean Sea near
the island of Elba in Italy.
Sponges are among the well-researched marine organisms primarily because of their
size and abundance. It is from sponges that 41% of discovered marine substances
have been isolated and hence they present an interesting source for the isolation of
marine fungi. 
The metabolites isolated from marine fungi which are considered candidates for new
drugs are antibacterial, antifungal, and cytototoxic. A comprehensive survey of
pharmacological activity conducted by the U.S. National Cancer Institute over a
period of 15 years, found that ca. 4% of the marine species (mainly animals)
examined contained antitumor compound(s) [Rinehart, 2000]. Although this may be
influenced by the investigation method used, it is also to be expected as these
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compounds represent important chemical defense mechanisms for marine
microorganisms. Hence, this study is centered on the isolation of metabolites from
fungal extracts which exhibit antibacterial, antifungal, and cytototoxic activites. For
the isolation of the metabolites, a combined chemically and biologically driven
approach will be used. Extracts are screened for antibacterial, antifungal, insecticidal,
cytotoxic, and general toxicity activities. To supplement the bioassay-guided
approach to purify the compounds responsible for the activity of the extract, TLC, UV
and MS are used to isolate the chemically most interesting substances. Hence,
purified compounds which are not responsible for the initial bioscreening activity may
have a chance to be evaluated for other more sophisticated bioactivities. 
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Fig. 1.3: Structures of metabolites from Leptosphaeria oraemaris
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2. Results
The result of bioscreening of different extracts (discussed in detail later) (Table 2.1),
the following materials were chosen for chemical investigations.
Table 2.1: Summary of bioscreening result showing the activities of the
mterials chosen for chemical investigation.
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A. Sponges
1. Jaspis splendens + + +
2. Agelas nakamurai - + -
B. Fungi
1. Cladosporim herbarum - + -
2. Curvularia lunata - + -
3. Penicillium sp. + + +
4. E00-12/11 - + +
5. Aspergillus flavus + + -
2.1. Metabolites isolated from sponge-derived fungi
2.1.1. Isolated compounds from Cladosporium herbarum (Persoon: Fries) Link
derived from Callyspongia aerizusa.
The ethyl acetate extract of C. herbarum exhibited activity against B. subtilis and S.
aureus but not against E. coli and C. albicans (Table 2.2). No activity was observed
in the cytotoxic, insecticidal and brine-shrimp lethality tests.
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Table 2.2:  Antimicrobial activity screening of the extract of C. herbarum.
Zone of Inhibition (mm)
Test Organism Petroleum
Ether Phase
Ethyl Acetate
Phase
n-Butanol
Phase
B. subtilis n.a. 9 11
S. aureus n.a. 13 11
E. coli n.a. n.a. n.a.
HB101 n.a. n.a. n.a.
C. albicans n.a. n.a. n.a.
*n.a. = no activity
Chemical investigation of the ethyl acetate extract yielded five structurally-related
polyketides, two furanoic acid derivatives, and a phthalide. Of these eight isolated
secondary metabolites, four are new compounds. The two furanoic acids: sumiki’s
acid and  its acetyl congener were eventually found to be active against B. subtilis
and E. coli. Since the HPLC chromatogram of the n-butanol extract showed only
sumiki’s acid, it was deduced that this metabolite is responsible for the antimicrobial
activity of the extracts. Hence, chemical investigation was concentrated on the ethyl
acetate extract.
2.1.1.1. Related macrolides found in the literature
Previously known fungal metabolites which contain twelve-membered lactone rings
are shown in Fig. 2.1a. These include recifeiolide which was isolated from
Cephalosporium recifei [Vesonder et al., 1971],  cladospolide A, B and C from
Cladosporium cladosporioides [Hirota et al., 1985a] and Cladosporium tenuissimum
[Fuji et al., 1995], and patulolides A, B, and C from Penicillium urticae S11r59
[Sekiguchi, et al. 1985; Rodphaya et al., 1986]. A dimeric pentaketide macrolide
named thiobiscephalosporolide A, the first dimeric thiomacrolide, was isolated from
Cephalosporium aphidicola [Ackland et al., 1984]. 
A more recent report described the isolation of the polyketide metabolites iso-
cladospolide B, pandangolide 1, pandangolide 2 and seco-patulolide 2 (Fig. 2.1b)
Results
16
together with the previously known cladospolide B from an unidentified fungus
obtained from an unidentified sponge collected in Indonesia [Smith et al., 2000]. It is
interesting to note that the fungal culture in this report was described as septate and
having colony color of light gray to olive, which agrees with the description of C.
herbarum. It would appear, however, that the unknown marine sponge from which
their fungus was isolated, described as bright orange and encrusting, differs from C.
aerizusa.
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Fig. 2.1b: Secondary metabolites isolated from an unidentified fungus from an
unidentified sponge (*absolute configuration)
2.1.1.2. Isolated compounds which are previously known fungal metabolites
The known compounds cladospolide B (compound 1) (Fig. 2.1a), iso-cladospolide B
(compound 2) (Fig. 2.1b) and pandangolide 2 (compound 3) (Fig. 2.1b) were
isolated. The similarity of the UV spectra of the two isomers, compounds 1 (λmax
206.3 nm) and 2 (λmax 206.8 nm) indicated that the two are structurally related.  Both
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gave base peaks at  229 [M+H]+ in the positive ion ESIMS (Fig. 2.2). The observed
difference in the retention times of  the two compounds in the HPLC analytical
system suggested that 2 is slightly more polar than 1. The 1H (Fig. 2.3) and 13C (Fig.
2.4) NMR spectra of the two compounds were also similar (Tables 2.3a and 2.3b). 
2.1.1.2.1. Cladospolide B (1, known compound)
The 13C NMR spectrum of 1 (Fig. 2.4) showed 12 carbon signals: one carboxyl, two
nonsubstituted olefinic carbons, three oxygen-bound methines, five methylenes, and
one methyl carbon.  It gave a molecular ion peak at m/z 229 [M+H]+ in its positive ion
ESIMS spectrum (Fig. 2.2) suggesting a molecular formula of C12H20O4. The COSY
spectrum (Fig. 2.5) showed that the five methylene protons were attached to one
another. Although their signals were clumped together as multiplets in the region
between δ 1.40 to 1.90, it was possible to distinguish the resonances of the
methylene protons H-6A and H-6B because of their correlations with H-5. Likewise,
the signals corresponding to the methylene protons H-10A and H-10B were
determined due to their correlations with H-11. H-11 further coupled with the methyl
protons H-12 while at the other alkyl end, H-5 coupled with H-4 with a magnitude of
3.6 Hz indicating that the two hydroxyl groups at C-4 and C-5 were cis-oriented. H-4
was also seen to be connected to the olefinic protons H-3 and H-2. The molecular
formula of the compound suggests that it must have a macrolide ring structure. The
NMR data matched that of cladospolide B from the literature [Fuji et al., 1995].
Stereochemistry
[CD: CD: ∆ε190 = -2.41; ∆ε225 = +5.044; ∆ε282 = +0.123]
The coupling constant of 12.2 Hz between the two olefinic protons H-2 and H-3 of 1
indicated a cis configuration. Two isomers of 1, namely, cladospolide A and C, both
of which have been previously isolated with 1 from Cladosporium tenuissimum [Fuji
et al., 1995], differ from cladospolide B in having a trans configuration of these
protons. Furthermore, a previous study [Hirota et al., 1985b] reported that
hydrogenation of the double bond between C-2 and C-3 also produced different
dihydroproducts of cladospolides A, B and C indicating different stereochemistries of
the three chiral centers. The two hydroxyl groups of 1 were proven to have a cis
Results
configuration due to the coupling constants of H-4 and H-5, as mentioned above.
Since the [α]D value (+30, c 0.1, MeOH) was comparable with that of cladospolide B
(+45, c 0.4, MeOH) [Fuji et al., 1995],  the absolute configuration of the isolated
compound is assumed to be identical to that of cladospolode B which has been
established as 4S, 5S (that of C-11 was not established) by synthetic studies [Fuji et
al., 1995]. 
Fig. 2.2: (
+[M+H]+)
+
OH
4
5
6
7
8
[M+H+MeOH]+
O
O
HO
1 2
39
10
12
11[M+H+2MeOH]+
OHOH[M+H]+ O 1
2
3
45
6
7
8
9
10
1112[M+Na]19
-ESIMS of compounds 1 (top
[M+K]+) and 2  (bottom)
O
Results
OH
1112
Fig. 2.4: 13C NMR o
OH5
620
O
O
OH
1
2
3
45
6
7
8
9
10
f compounds 1 (top) and 2 (bottom).
O
O
HO
1 2
3
4
7
8
9
10
12
11
Results
21
Fig. 2.5: COSY spectrum 
2.1.1.2.2. Iso-cladospolide B (2, known comp
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of 2 with those of iso-cladospolide B isolated from an unidentified fungus derived
from an unidentified sponge [Smith et al., 2000] confirmed that the two are identical.
Stereochemistry
[CD: CD: ∆ε190 = +6.43; ∆ε213 = -11.54; 284 = +0.093]
The protons H-4 and H-5 were seen to be cis oriented as deduced from the coupling
constant of 3.6 Hz between the two protons. The comparable [α]D values observed
for 2 (–62o ,c 0.53, MeOH) and iso-cladospolide B (-90o, c 0.23, MeOH) [Smith et al.,
2000] indicate that they are the same compound. The absolute configuration of C-4
and C-5 in iso-cladospolide B was established by synthesis in a separate study
[Franck et al., 2001]. 
OHOH22
Fig. 2.6: HMBC spectrum of compound 2
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2.1.1.2.3. Pandangolide 2 (3, known compound)
Compounds 3-5 (Fig. 2.1a,b and Fig. 2.9) exhibited highly similar 1H (Table 2.3a) and
13C (Fig. 2.11) (Table 2.3b) NMR spectra, from which it can be deduced that all three
of them possess common structural features which distinguish them from 1 and 2.
The loss of unsaturation of C-2 and C-3 is one such feature. C-4 was also oxidized to
a keto carbon and all three also have a thioalkyl side chain attached to C-3. 
Compound 3 showed a molecular ion peak at m/z 318 [M]+ with EIMS (Fig. 2.7). An
intense ion peak at m/z 319 i[M+H]+ in the positive ion ESIMS furthered verified the
molecular mass which is compatible with the molecular formula C14H22O6S. The
COSY spectra (Fig. 2.8) showed the presence of three separate spin systems.  The
first consists of a methyl group, two  methines which are geminally attached to
oxygen substituents, and five methylenes. The second spin system includes a
methylene H-2A and H-2B which coupled with a methine H-3. The third spin system
consists of a diastereotopic methylene H-13A and H-13B which was shown by the
HMBC spectrum to be attached to a carboxyl. The chemical shifts of H-3 (δ 3.67) and
of C-3 (δ 41.2), as well as those of H-13A and H-13B (δ 3.36 and 3.26, respectively)
and of C-13 (δ 35.0), ruled out  an oxygen-containing substituent and the presence of
a sulfide linking the two spin systems was proposed. The NMR data of 3 (Table 2.3a
and 2.3b) was similar to published data from the previously isolated pandangolide 2
[Smith et al., 2000]. 
Stereochemistry
[CD: CD: ∆ε214 = -1.196; ∆ε223 = -0.363; ∆ε247 = +1.720; ∆ε287 = -0.323; ∆ε342=+0.103]
The observed [α]D value of –57o (c 0.72, MeOH) of 3 was similar with that of
pandangolide 2 (-30, c 0.19, MeOH) [Smith et al., 2000] suggesting that the two
compounds are identical. Attempts at determining the relative stereochemistry of C-3
and C-5 of compound 3 by recording the ROESY spectrum of the compound was not
successful (Fig. 2.8). No correlation was seen between H-3 and H-5 probably due to
the flexibility of the bonds in the macrolide ring. Performing the Mosher reaction
would only have established the stereochemistry at C-5 and possibly at C-11 after
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hydrolysis of the lactone bond. However, due to low yield this reaction was not
attempted.
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Table 2.3a.  1H NMR (CD3OD) data* for compounds 1-5
Atom 1 2 3 4 5
2a 5.74 (dd, 12.2, 1.5) 6.21 (dd, 5.8, 1.9) 3.34 (dd, 19.4, 12.7) 3.49 (dd, 19.4, 12.4) 3.46 (dd, 19.4, 12.7)
2b 2.91 (dd, 19.4, 3.4) 3.00 (dd, 19.4, 3.8) 2.95 (dd, 19.4, 3.8)
3 6.41 (dd, 12.2, 8.2) 7.69 (dd, 5.8, 1.6) 3.67 (dd, 12.7, 3.4) 3.72 (dd, 12.4, 3.8) 3.98 (dd, 12.7, 3.8)
4 5.31 (ddd 8.2, 3.2,
1.5)
5.12 (ddd, 3.6, 1.9, 1.6)
5 3.72 (dd, 3.2, 10.2) 3.83 (dd, 7.6, 3.6) 3.92 (dd, 7.1, 3.7) 4.05 (dd, 8.0, 3.6 ) 4.06 (dd, 7.9, 3.3)
6a 1.85 (m) 1.61 (m) 1.70 (m) 1.88 (m) 1.88 (m)
6b 1.50 (m) 1.61 (m) 1.70 (m) 1.88 (m) 1.88 (m)
7a 1.40-1.80 (m) 1.45 (m) 1.05 (m) 1.64 (m) 1.67 (m)
7b 1.40-1.80 (m) 1.45 (m) 1.50 (m) 1.27 (m) 1.27 (m)
8a 1.40-1.80 (m) 1.45 (m) 1.00-1.40 (m) 1.27 (m) 1.27 (m)
8b 1.40-1.80 (m) 1.45 (m) 1.00-1.40 (m) 1.27 (m) 1.27 (m)
9a 1.40-1.80 (m) 1.45 (m) 1.00-1.40 (m) 1.47 (m) 1.47 (m)
9b 1.40-1.80 (m) 1.45 (m) 1.00-1.40 (m) 1.27 (m) 1.27 (m)
10a 1.85 (m) 1.50 1.55 (m) 1.64 (m) 1.67 (m)
10b 1.85 (m) 1.50 1.35 (m) 1.47 (m) 1.47 (m)
11 4.9 (m) 3.74 (m) 4.65 (m) 4.9 (m) 4.88 (m)
12 1.32 (d, 6.1) 1.32 (d, 6.1) 1.10 (d, 6.1) 1.23 (d, 6.2) 1.10 (d, 6.1)
13a 3.26 (d, 15.4) 3.12 (dd, 13.9, 6.5)
13b 3.36 (d, 15.4) 3.06 (dd, 13.9, 5.5)
14 4.41 (dd, 5.5, 6.5)
15
16 3.79 (s)
* presented here as δ signal (multiplicity, J in Hz)
Table 2.3b. 13C NMR data for compounds  1-5
Carbon Atoms
1
(CD3OD)
2
(CD3OD)
3
(DMSO-d6)
4
(CD3OD)
5
(CD3OD)
1 167.6 175.8 169.5 172.5 174.5
2 121.1 122.7 40.5 42.2 41.9
3 152.1 157.1 41.2 43.7 43.6
4 75.7 88.2 213.9 215.0 214.5
5 75.3 71.6 75.6 77.8 77.7
6 32.5 34.2 30.9 32.4 32.4
7 25.9 26.8 20.4 21.7 21.6
8 26.9 30.6 27.5 29.0 29.0
9 21.5 26.8 22.3 23.7 23.6
10 33.0 40.1 32.5 34.1 34.0
11 68.0 68.5 72.0 74.4 74.5
12 21.3 23.5 19.6 20.0 19.9
13 - - 35.0 36.6 -
14 - - broad peak 72.0 -
15 - - - 174.5 -
16 - - - 52.6 -
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2.1.1.3. New isolated compounds 
O O O
OO
O O
OH HO
S
[4] Pandangolide 3 [5] Pandangolide 4
S
COOCH3
OHOH
O
O
Fig. 2.9: Structures of new compounds 4 and 5
2.1.1.3.1. Pandangolide 3 (4, new compound)
HREIMS m/z 362.1391(calcd for C16H26O7S, 362.1399)
[α]D –57 (c, 0.72, MeOH)
 CD: ∆ε215 = -1.627; ∆ε227 = -0.172; ∆ε240 = +1.726; ∆ε363 = 0.043
Compound 4 (Fig. 2.9) was obtained as an oil which showed a base peak in the
positive ion ESIMS at m/z 363 [M+H]+, and a molecular ion peak at m/z 362 [M]+ with
EIMS (Fig. 2.10). The exact mass of this ion, which was measured by HREIMS to be
362.1391, corresponds to the molecular formula C16H26O7S. 
Fig. 2.10: EIMS spectrum of compound 4
.
[M-H2O]+.
[M]+
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The 13C NMR spectrum (Fig. 2.11) of 4 was remarkably similar to that of 3, with an
additional lowfield signal from a methine carbon (C-14) at 72.0 ppm indicating an
oxygen-bound carbon. Another lowfield signal at 52.6 ppm suggested a methoxyl
carbon (C-16) which was attached to C-15, based on an HMBC correlation of H3-16
(δ 3.79) with C-15 (δ 174.5) (Fig. 2.16). Correlations between H2-13 and H-14 in the
COSY spectrum (Fig. 2.12) as well as between H2-13 with C-14 and C-15,
respectively, in the HMBC spectrum, revealed the connectivities  in the sulfur-
containing side chain. The position of the sulfide group with respect to the
macrocyclic lactone ring was evident from a long-range correlation between H-13
and C-3, and vide infra. The positions of C-1 to C-6 were established from
correlations between H2-2, H-3, H-5, and H2-6 with C-4, and H2-2 as well as H-3 with
C-1, respectively. The assignments of C-7 to C-10 were based on key HMBC
correlations between H-5 with C-7, H-6B with C-8, and H3-12 with C-10, respectively. 
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Fig. 2.12: COSY spectrum of pan
Important correlations from the HMBC spectrum of pa
the point of attachment of the sulfide side chain as
therein are shown below (Fig. 2.13).
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Fig. 2.13: HMBC spectru
2.1.1.3.2. Pandangolide 4 (5, new compou
HREIMS:  m/z  486.2276 [M]+ (calcd for c24H
 [α]D –55.1 (0.53, MeOH)
 CD: ∆ε215 = 0.166; ∆ε227 = -1.183; ∆ε240 = +0
Compound 5 was obtained as an oil whose
intense pseudo molecular ion peak at 
OH OHm of pandangolide 3
nd)
38O8S, 486.2287)
.050; ∆ε363 =+0.0.059
 positive ion ESIMS spectrum showed an
m/z 487 ([M+H]+). EIMS (Fig. 2.14)
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measurement gave a molecular ion peak at m/z 486. It has a molecular weight of
486.2276 as measured by HREIMS, corresponding to the molecular formula
C24H38O8S. 
Fig. 2.14: EIMS spectrum of pandangolide 4
The 13C NMR spectrum (Fig. 2.11) showed only 12 signals while integrat
proton signals in the 1H NMR spectrum yielded only 19 protons suggesting 
symmetrical dimer. The 13C NMR spectrum was similar to that of pandang
and 3 (4) but with the absence of the alkyl side chain. The similarity in the
shifts of C-2 and C-3 in 3, 4, and 5 indicates that in 5 the sulfide was ret
instead of being linked to an alkyl side chain, it bridged two identical m
lactone rings to form the dimer. This was corroborated by EIMS signals a
(Fig. 2.14), which corresponds to the mass of a monomer, and at 
corresponding to a monomer with a thiol group. Furthermore, the dimeric s
5 was proved by the HMBC spectrum where H-3, aside from showing 
direct orrelation signal with C-3, also gave a long-range correlation
respective carbon C-3' (Fig. 2.16). As in compounds 1-4 assignments 
signals H-6 to H-10 were possible from correlations in the COSY spec
2.15).
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Fig. 2.15: COSY spectrum of p
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As with 4, attempts at determining the relative stereochemistry of C-3 and C-5 in 5
proved unsuccessful when measurement of its NOESY and ROESY spectra in two
different instruments exhibited no significant NOEs involving H-5, H-3 as well as H-
12. This may have been due to the flexibility of the bonds in the macrolide structure.
Mosher reaction, which could have established the absolute stereochemistry of C-5
and C-11 (after hydrolysis) of both compounds, as well as of C-14 of 4, was not
performed due to the limited amounts isolated.
Bioactivity
In agreement with previous reports [Smith et al., 2000] compounds 1-5 were inactive
when tested against Gram-positive and Gram-negative bacteria. This appears to
confirm previously drawn observations that antimicrobial activity of these macrolides
requires the presence of a double bond flanked by two carbonyl carbons, which are
common in other antimicrobial agents such as pyrenophorin, pyrenolides, and
vermiculine [Rodphaya et al., 1986].
Likewise, the isolated macrolides also exhibited no activity against A. salina, S.
littoralis, and human leukemia cell lines. 
2.1.1.4. Furan carboxylic acid derivatives
O COOH
O
O COOH
HO
O
12
34
5
6
12
34
5
6
7
8
(6) sumiki's acid (7) acetyl sumiki's acid
Fig. 2.17: Structures of isolated furanoic acid derivatives
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2.1.1.4.1. Sumiki’s acid (6, known compound)
Compound 6 (Fig. 2.17), which was isolated as a brown oil, is a known fungal
metabolite originally isolated from Penicillium italicum and Pyricularia grisea
[Kawarada et al., 1955; Munekata and Tamura, 1981]. Sumiki’s acid gave an
molecular ion peak at m/z 142 in EIMS (Fig. 2.18). This molecular mass was
compatible with the molecular formula C6H6O4. The 13C (Fig. 2.21) and DEPT spectra
showed five sp2 carbons: the two at δ 119.9 and δ 110.2 were unsubstituted and of
the three  substituted carbons, two gave lowfield signals at δ 161.9 and δ 160.6. An
oxygen-bound methylene carbon at δ 57.5 was also observed. The two olefinic
protons  coupled at a magnitude of 3.4 Hz  compatible with protons in a furan ring.
The 13C and 1H of 6 matched those of sumiki’s acid as described in the literature
[Munekata and Tamura, 1981]. Additional proof of the proposed structure was given
by the fragmentation pattern in the EIMS (Fig. 2.18). Ion peaks at m/z 125 and 97
correponding to [M–OH]+ and [M–COOH]+, respectively, were observed.
2.1.1.4.2. Acetyl sumiki’s acid (7, new compound)
Compound 7, which was also isolated as a brown oil, gave a molecular ion peak at
m/z 184 in EIMS (Fig. 2.18). An additional ion peak at 142 was also observed which
could be  [M – COCH3]+. It exhibited a similar fragmentation pattern as 6, showing ion
peaks at m/z 125 and 97 corresponding to [M–OH]+ and [M–COOH]+, respectively.
Likewise, the UV spectra of 6 (maximum absorption at 260 nm) and 7 (maximum
absorption at 256 nm) were nearly identical (Fig. 2.19). 
The 1H NMR spectra of both compounds (Fig. 2.20) (Table 2.4) were also very
similar. The differences include the downfield shift of H-6 from 4.61 in 6 to 5.14 in 7,
together with an extra methyl group signal at 2.11 ppm in 7. These and the MS data
established the structure of 7. 
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Fig. 2.18: EIMS spectra of compound 7 (to
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Fig. 2.19: UV spectra of compound 6 (left) and 7 (right)
Table 2.4: 1H NMR (CD3OD) data for  compounds 6 and 7
Carbon
Atoms
13C 1H 1H
6 6 7
1 161.9
2 145.9
3 119.9 7.19 d, J = 3.5 7.16 d, J = 3.4
4 110.2 6.50 d, J = 3.5 6.61 d, J = 3.4
5 160.6
6 57.5 4.60 s 5.14 s
7
8 2.11 s
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Fig. 2.20: 1H NMR of compounds 6 (top) an
Fig. 2.21: 13C NMR spectrum of compoun
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Bioactivity
Sumiki’s acid was reported to exhibit some antitumor activities against SV40-
transformed cels [Munekata and Tamura, 1981]. When tested agaisnt human
leukemia cell lines, the isolated sumiki’s acid (compound 6), however, was inactive. It
was also inactive against A. salina and against the polyphagous insect, S. littoralis.
It was, however, found to be moderately active against S. aureus and B. subtilis
(Table 2.5) and against C. albicans (Table 2.6).
Table 2.5: Agar plate diffusion assay data of compounds 6 and 7.
B. subtilis S. auerus E. coli
EtOAc Phase (1 mg) 9 mm 13 mm n.a.
n-BuOH Phase (1 mg) 11 mm 11 mm n.a.
Petroleum Ether Phase (1 mg) n.a. n.a. n.a.
compound 6 (5 µg) 7 mm 7 mm n.a.
compound 7 (5 µg) 7mm 7 mm n.a.
*Filter disk diameter is 5.5 mm
Table 2.6: Antimicrobial activity of of various concentrations of compound 6
against C. albicans in agar plate diffusion assay.
Loading
Concentration
(µg/disk)
Zone of
Inhibition
(mm)
1 12
5 12
10 18
50 18
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2.1.1.5. Herbaric acid (8, new compound)
O
HO
OH O
COOH
2
1
765
4 3 9
8
10 11
(8) Herbaric acid
Fig. 2.22: Structure of compound 8
Compound 8 (Fig. 2.22) was obtained as a brown, amorphous powder. The
molecular formula was deduced as C10H8O6 by HREIMS. Its structure was
established through 1 D (1H  and 13C) and 2 D (COSY, HMQC and HMBC) NMR
(Table 2.7). The 13C NMR spectrum (Fig. 2.23) showed 10 carbon atoms: two
carboxyl carbons (173.0 and 171.4); six aromatic carbons, two of which are oxygen-
substituted; an oxygen-substituted tertiary carbon; and one methylene group. The 1H
NMR (Fig. 2.24) and COSY spectra showed two meta-coupled aromatic protons at
δ 6.42 and 6.30 (4J = 1.6 Hz), a methylene at δ 2.91 and 2.73 with a geminal coupling
constant of  16.5 Hz which further coupled to a methine at  δ 5.68 (3J = 5.2  and 3J =
7.9 Hz, respectively). The proposed structure of herbaric acid and the assignment of
NMR signals were both confirmed by HMQC and HMBC (Fig. 2.25). An apparent
long range coupling between H-6 and H-7 (4J  = 0.9 Hz) was also confirmed through
a homonuclear spin decoupling experiment (Fig 2.26), where irradiation at δ 5.68
(expected H-7 signal) gave an NOE effect on H-6. Furthermore, a long range
correlation between H-6 and C-7 was also observed in the HMBC spectrum (Fig.
2.25). This, and a long range correlation due to W-bond coupling between H-4 and
C-2 established the fused ring structure. The EIMS spectrum (Fig. 2.27) provided
additional proof of the proposed structure, with strong ion peaks at m/z 178 and 165
corresponding to the loss of [HCOOH]+ and [CH2COOH]+,  respectively.
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Table 2.7: NMR data for compound 8 (7) in DMSO-d6 at 600 MHz.
Position 13C 1H HMBC
Correlations
2 171.4 (s) - -
3 159.7 (s) - -
4 103.9 (d) 6.30 (d, 1.6) C2, C3, C5, C9 
5 167.1 (s) - -
6 101.7 (d) 6.42 (dd, 1.6, 0.9) C5, C4, C7
7 78.2 (d) 5.68 (br dd, 7.9, 5.2) C8, C10, C11
8 154.8 (s)
9 104.5 (s)
10 A 40.4 (t) 2.91 (dd,  5.2, 16.5) C7, C8, C11
10 B 2.73 (dd,  7.9, 16.5) C7, C8, C11
11 173.0 (s)
Fig. 2.23: 13C NMR spectrum of compound 8
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Fig. 2.24: 1H NMR spectrum of compound 8
Fig. 2.25: HMBC spectrum of co
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Fig. 2.28: Metabolites isolated from curvularia lunata
2.1.2.1. (+)-Abscisic acid (9, known compound)
Abscisin II or dormin is a monocylic sesquiterpene of universal occurrence in higher
plants, such as sycamore, birch, rose, cabbage, potato, lemon, etc. It has also been
isolated from phytopathogenic fungi such as Cercospora cruenta (fungus responsible
for the leaf spot and pod blight disease complex in plants) [Oritani and Yamashita,
1985], Macrophoma castaneicola (fungus responsible for the black root disease in
chestnuts, Cercospora rosicola [Assante et al., 1977], Botrytis cinerea [Marumo et al.,
1982], and Laminaria sp. (Phaeophyta) [Schaffelke, 1995]. It’s presence in
commercial seaweed products as well as in marine algae [Crouch and Vanstaden,
1993] has also been documented, but this is the first time that abscisic acid has been
isolated from a marine-derived fungus. 
Structure Elucidation 
Compound 9 (Fig. 2.28), which was isolated as a white amorphous powder, was the
major metabolite produced by Curvularia lunata. It gave a molecular ion peak at m/z
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264 in the EIMS spectra (Fig. 2.29). A fragment ion was also seen at m/z 246
corresponding to the loss of the hydroxyl group. The 13C (Fig. 2.30) and DEPT
spectra showed 15 carbons: one carbonyl; one carboxyl; six sp2 carbons including
one which is oxygen-bound; two quaternary sp3 carbons of which one is directly
bound to oxygen; one methylene and four methyl groups. The molecular formula was
therefore established to be C15H20O4. The 1H and 13C NMR spectral data (Fig. 2.30)
(Table 2.9) matched those of (+)-trans abscisic acid [Ohkuma and Addicott, 1965;
Constantino, et al., 1986]. Likewise, the EIMS spectra of compound 9 is also identical
with that of (+)-abscisic acid [Constantino, et al., 1986; Schaffelke, 1995]. The HMQC
and HMBC spectra of 9 also confirmed the proposed structure.
Stereochemistry
The coupling constant of 15.8 between H-4 and H-5 established the trans
configuration of the double bond between C-4 and C-5, as is the case in abscisic
acid. Likewise, the chemical shifts of C-2 and C-3 in compound 9, which matched
that of natural (+)-abscisic acid, also confirmed the cis configuration of the α, β-
double bond. The stereochemistry at the chiral center C-1' of compound 9 is also
identical with that (+)-abscisic acid due to the similarity in their [α]D values.
Compound 9 gave a  [α]D value of +138.35 (c. 0.47, EtOH) which is similar to the
literature value of + 383o (c 0.23, EtOH) [Assante et al., 1977]. Furthermore, the
recorded CD spectra of the compound 9: ∆ε203 = -5.776; ∆ε232 = -35.808; ∆ε264 =
43.718; ∆ε323 = -2.146 also agreed with literature data: ∆ε230 = -34; ∆ε262 = +39.5;
∆ε318 = -2.5) [Harada, 1973].
Bioactivity
(+)-Abscisic acid is active as a growth and development regulator [Milborrow, 1968].
Only the natural (S)-isomer is active in stomatal closure [Milborrow and Garmston
1973] whereas both enantiomers are active as germination and growth inhibitors.
When tested for antimicrobial, insecticidal and brine-shrimp lethality tests, compound
9 did not show activity.
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Fig. 2.29: EIMS spectrum of compound 9
Fig. 2.30: 13C and 1H NMR spectra of compound 9
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Table 2.9: NMR data of compound 9 in DMSO-d6  at 300 MHz
Number  13C 1H HMBC
1 166.8 s
2 118.3 d 5.67 (s) C4, C3, C1, C6
3 149.2 s
4 127.2 d 6.22 (d, 15.8) C5, C2, C6, C1', C3, C2'
5 137.4 d 7.72 (dd, 15.8, 0.5) C2, C4, C3, C2', C6', C1'
6 18.8   q 1.97 (d, 1.1) C3, C4, C2 
1' 78.3   s
2' 163.1 s
3' 125.9 d 5.19 (s) C7' C5', C1'
4' 197.2 s
5'α 49.3   t 2.53 (br d, 16.5) C3', C1', C6', C8', C9'
5'β 2.11 (br d, 16.5) C3', C1', C6', C8', C9'
6' 41.2  s
7' 24.1  q 1.82 (d, 1.13) C2', C1'’, C5, C3', 
8' 23.2  q 0.92 (s) C1', C5', C6', C9'
9' 20.8  q 0.96 (s) C1' C5', C6', C8'
C-1 O-H 12.05 (s)
C-1'O-H 5.19 (s)
2.1.2.2. Anthraquinones
Anthraquinones are widely distributed among microorganisms, plants, echinoderms,
and insects [Thomson, 1997]. More than 500 anthraquinones have been isolated
from natural sources [Ibid]. Some of these are used as purgatives (rhubarb, senna)
and laxatives (emodin and danthron). Furthermore, several natural and synthetic
hydroxy- and methyl- anthraquinones exhibit mutagenicity and are used as standards
in the Ames/Salmonella assay [Krivobok et al., 1992]. In a study of the structure-
mutagenicity relationships of various hydroxy- and methyl-substituted anthraquinones
(emodin, danthron, physion) and of dimeric compounds (skyrin, rugulosin and
rugulin), it was found out that 1- and 8-hydroxylation of the anthraquinone moiety
(danthron) markedly increased the mutagenicity [Ibid]. It was also reported [Liberman
et al., 1982] that mutagenicity decreases when hydroxylation occurs in other
positions, for example with alizarin (7,8-dihydroxyanthraquinone). Other
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anthraquinones with antitumor and cytotoxic activities are also found in the literature
[Solis, et al., 1995; El-Gamal et al., 1995].
Some dimeric anthraquinones, also known as bisanthraquinones are shown in Fig.
2.31. Luteoskyrin and rugulosin are known to interact with DNA [Ueno, et al., 1967;
Ueno et al., 1968]. Luteoskyrin has been reported to produce a BIA (Biochemical
Induction Assay) response at 500 ng after extended periods of incubation [Elespuru
and White, 1983]. Luteoskyrin was also reported to exhibit cytotoxicity to Reuber
hepatoma H4-II-E and fibroblast Balb/3T3 cells [Akuzawa et al., 1992]. Rugulosin
was also reported to alter DNA [Ueno and Kubota, 1976] and to bind to DNA in vitro
without metabolic activation [Yoshikazu et al., 1976]. 
O
O
O
O
OH
OH
OH
HO
OH
OH
OH OH
CH3
H3C
H
H
H
H
H
H
O
O
O O
OH
OH
OH
HO
OH
OH
CH3
H3C
H
H
(-)-luteoskyrin (+)-rugulosin
O
O
O
O
OH
OH
HO
OH
OH
OH
H3C
CH3
H
H
H
H
H
H
graciliformin
Fig. 2.31: Structures of related bisanthraquinones 
previously isolated from fungi
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2.1.2.2.1. Cytoskyrin A (10, known compound)
Cytoskyrin A  was originally reported from the endophytic fungus Cytospora sp.
isolated from the plant Conocarpus erecta [Brady et al., 2000]. 
Compound 10 (Fig. 2.28) which was isolated as a yellow amorphous powder, was
identified on the bases of IR, HREIMS, [α]D, 1H, 13C, HMBC and HMQC NMR data. It
gave a molecular ion peak at 574 by EI (Fig. 2.32) and an exact mass of 574.1102
which corresponds to the molecular formula C30H22O12. A fragment ion was also seen
at 287 corresponding to a monomeric ion. The IR spectra (Fig. 2.33) showed a peak
at 1704 and 1603 corresponding to the non-chelated C-10/C-10' and chelated C-9/C-
9' carbonyls, respectively. 
Fig. 2.32: EIMS of compound 10
Fig. 2.33: IR spectra of compound 10
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Compound 10 is a symmetrical dimer so that the 1H (Fig. 2.34) and 13C NMR spectra
(Fig. 2.35) showed only signals corresponding to the monomer. The proton NMR
showed one pair of doublets at 6.95 and 6.83 ppm with coupling constants of 2.2 Hz
corresponding to the meta-coupled aromatic protons. A singlet at 11.69 ppm
corresponds to the phenolic proton attached to C-8.  A broad singlet at 14.40 ppm
corresponds to the phenolic proton attached to C-1 (spectra not shown). The H-H
COSY spectrum showed correlations between H-2 and H-3 and between H-3 and H-
4 which attest to the vicinal positions of these three protons. The COSY spectrum
also showed a long range correlation between H-2 and H-4. The hydoxyl proton (C-
3—OH) which was shown as a singlet at 5.37 ppm also showed correlations with H-2
and H-4. Furthermore, long range correlations of H-2 with C-3 and C-4 and of H-4
with C-2 and C-4 were also observed. However, despite these correlations, there
was no observed coupling between the signals of H-2, H-3 and H-4 in the 1H NMR
spectrum, with all of them appearing as singlets. 
The rigid W configuration in which H-2, H-3, and H-4 are held in the central cage
structure, allows for the determination, based on the Karplus equation, of the relative
stereochemistry of C–2, –3, and –4 in related bisanthraquinones. CS Chem 3D Pro
chemical modeling was able to predict that the experimentally observed coupling
pattern will occur if the H-2, -3, and –4 protons have an all cis configuration within
monomers of cytoskyrin A. The dihedral angles H2–C2–C3–H3 and H3–C3–C4–H4
were shown to approach 90o when a cis, cis configuration of each vicinal proton pair
was applied on the molecular model. This also agrees with the dihedral angles
measured from Dreiding models. Likewise, the dihedral angle in H4-C4-C4’-H4’ was
computed to be 84.9o which explains the absence of coupling between these protons. 
Meanwhile, the presence of long range correlations between H-2 and the carbons C-
4a' and C-10'  provided proof that the compound is a dimer (Fig. 2.36a and Fig.
2.36b). NMR data are shown in Tables 2.10a and 2.10b.
The cis, cis configuration for the protons H-2, -3, and –4 of cytoskyrin A in the
literature was confirmed by the X-ray crystallography structure [Brady et al, 2000].
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The [α]D value observed for compound 10 (+393, c 0.184, dioxane) was in agreement
with that reported for cytoskyrin A (+328, c 1.0, Acetone + 0.2% TEA) [Ibid], thus
proving that the two are identical.
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Fig. 2.35: 13C NMR of compounds 10 (top) and 11
O
O
O O
OH
OH
HO
OH
OH
OH
H3CO
OCH3
H
H
H
H
H
H
4
32
1 1a
4a
9
10
8a
5a
8
5
7
6
11
4'
3' 2'
1'
1'a
4'a
5'a
9'
10'
5'
8'
6'
7'
11'
8'a
O
O
OH
OH
OH
H3CO
H
H
H
H
9
10
8
7
6
1
45
8a
5a
1a
4a
2
3
110.51.01.5.0
10
O
O
O O
OH
OH
HO
OH
OH
OH
H3CO
OCH3
H
H
H
H
H
H
4
32
1 1a
4a
9
10
8a
5a
8
5
7
6
11
4'
3' 2'
1'
1'a
4'a
5'a
9'
10'
5'
8'
6'
7'
11'
8'a (bottom).
Results
54
O
O
O O
OH
OH
HO
OH
OH
OH
H3CO
OCH3
H
H
H
H
H
H
4
32
1 1a
4a
9
10
8a
5a
8
5
7
6
11
4'
3' 2'
1'
1'a
4'a
5'a
9'
10'
5'
8'
6'
7'
11'
8'a
Fig. 2.36a: Important correlations from the HMBC spectrum of compound 10
Fig. 2.36b: HMBC spectrum of compound 10
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2.1.2.2.2. Lunatin (11, new compound)
Compound 11 (Fig. 2.28) was obtained as an orange-colored amorphous powder. It
showed a molecular ion peak at m/z 286 in EIMS (Fig. 2.37). Its molecular formula
was determined by HREIMS to be C15H10O6. Its structure was established through
1 D (1H, 13C and DEPT) and 2 D (COSY and HMBC) NMR (Tables 2.10a and 2.10b).
The 1H NMR spectrum showed two phenolic protons at δ 12.31 and 12.22 (spectra
not shown), two pairs of meta-coupled protons  at δ 7.14 and 6.82 (4J = 2.5 Hz) and
at δ 7.09 and 6.56 (4J = 2.3 Hz) and a methoxyl group at δ 3.91. The 13C NMR (Fig.
2.35) and DEPT spectra revealed 15 carbon atoms: two quinone carbonyls, twelve
aromatic carbons, and one methoxyl. Of the aromatic carbons, 4 were unsubstituted
and of the substituted carbons, 4 were oxygen-bound. The proposed structure of
compound 12 and the assignment of NMR signals were corroborated by data from
the HMBC spectrum (Table 2.10b). Furthermore, the assignment of the proton
signals was also made possible through an NOE experiment which showed selective
enhancement of the signals for H-5 and H-7 after irradiation at δ 3.91 (H-11 signal)
thereby establishing the position of the methoxy group (Fig. 2.38). 
A lichen metabolite with a proposed structure identical to that of 11 was recently
reported [Ivanova et al., 2000]. However, important differences in chemical shift data
were observed such as the 1H NMR data for H-4, the coupling constant between H-2
and H-4, as well as 13C NMR data for C-1a, C-2 and C-4. In addition, a disparity in
the chemical solution behavior of the two compounds, in which 11 was insoluble in
CHCl3 which was the solvent used for the measurement of the NMR spectra of the
lichen metabolite, also proved that the two compounds are not identical. The lichen
metabolite could thus possibly be an isomeric compound although this aspect needs
further clarification. 
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Table 2.10a: 13C NMR data  for compounds 10 and 11 in DMSO-d6 at 400 MHz
and 300 MHz, respectively.
Atom
Number
10 11
1 184.0 (s) 164.4 (s)
1a 104.2 (s) 108.3 (s)
2 60.6 (d) 108.1 (d)
3 72.4 (d) 165.9 (s)
4 49.5 (d) 109.3 (d)
4a 58.9 (s) 134.6 (s)
5 106.3 (d) 107.4 (d)
5a 135.8 (s) 134.8 (s)
6 165.5 (s) 165.5 (s)
7 106.3 (d) 106.6 (d)
8 162.6 (s) 164.1 (s)
8a 110.9 (s) 109.6 (s)
9 184.1 (s) 188.4 (s)
10 193.3 (s) 181.1 (s)
11 56.2 (s) 56.2 (q)
Table 2.10b: 1H and HMBC NMR data of compounds 10 and 11 in DMSO-d6 at
400 MHz and 300 MHz, respectively
H 1H (m, J in
Hz)
10
HMBC Correlations 1H (m, J in
Hz)
11
HMBC
Correlations
1
1a
2 2.77 (s) C2 (direct), C1, C1a, C3, C4,
C4a, C10
6.56 (d, 2.3) C1, C1a, C3
3 3.95 (s) C3 (direct), C1, C2, C4, C4a 
4 3.91 (s) C1a, C2, C4, C4a’, C10’ 7.09 (d, 2.3) C1a, C3, C10
4a
5 6.95 (d, 2.2) C5 (direct), C6, C8a, C10 7.14 (d, 2.5) C7, C8a, C10
5a
6
7 6.83 (d, 2.2) C7 (direct), C6, C8, C8a, 6.82 (d, 2.5) C5, C6, C8, C8a
8
8a
9
10
11 3.91 (s) C11 (direct), C11 3.91 (s) C6
C3-OH 5.37 (s)
C8-OH 11.69 (s) 12.31 (s)
C1-OH 14.40 (s) 12.22 (s)
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Bioactivity
Cytoskyrin A (10) was reported to show strong biochemical induction assay (BIA)
activity down to 12.5 ng in the standard assay [Brady et al., 2000]. BIA is a rapid
(colorimetric) bacterial assay which measures the induction of the SOS response in
bacteria and is used to identify compounds that inhibit DNA synthesis either directly
by inhibiting the DNA replication machinery or more often indirectly by modifying
DNA. Preliminary studies was also reported to show that cytoskyrin A inhibits both in
vitro DNA synthesis and transcription to a greater extent than either luteoskyrin or
cytoskyrin B [Ibid].
In this study, cytoskyrin A (10) was tested for activity against human leukemia HL-60
cell line. The result showed inhibition of cell growth by 35% when applied in
concentration of 5 µg/ml. Lunatin (11) on the other hand, exhibited no activity.
Antimicrobial tests showed that both anthraquinones, 10 and 11, were active against
S. aureus, E. coli, and B. subtilis but had no activity against C. albicans (Table 2.11).
A comparative test on their activities against S. aureus indicated that compound 11
was slightly more potent than compound 10 (Table 2.12).
Table 2.11: Zones of inhibition in agar-plate diffusion assay.
Compound S. aureus E. coli E. coli
HBI-101
B. subtilis C. albicans
11
(5 µg) 8.5 cm 9.0 cm 8.0 cm 7.5 cm n.a.
(10 µg) 10.0 cm 11.0 cm 10.5 cm 9.0 cm n.a.
10
(5 µg) 8.5 cm 9.0 cm 8.0 cm 8.0 cm n.a.
(10 µg) 10.0 cm 11.0 cm 9.0 cm 12.0 cm n.a.
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Table 2.12: Agar plate diffusion assay for compounds 10 and 11
Amount
(µg)
Zone of inhibition
(mm) against
S. aureus
10 11
1 15 n. a.
5 15 12 
10 15 14 
2.1.3. Isolated compounds from fungi derived from Axinella verrucosa
Twenty-two fungi species were isolated from the sponge Axinella verrucosa which
was collected in Secca di Corallo, Elba, Italy. Bioscreening of the ethyl acetate
extracts of these fungi showed the extract E00-12/3 which later identified as
Penicillium sp. as exhibiting strong activities (Fig. 2.39; Table 2.13). An unidentified
fungus E00-12/11 which exhibited antifeedant activity (30% growth rate) against
Spodoptera littoralis was also chemically investigated when its HPLC chromatogram
showed only one major metabolite.
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Fig. 2.39: Bioscreening result of 21 extracts of various fung
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Table 2.13: Bioscreening result of the extracts of 22 fungal strains isolated
from Mediterranean sponges.
Brine-shrimp Mortality
Rate
Sample
from 300 mL
Fungal Culture 500 µg 50 µg
Insect
Mortality
Insect Growth
Reduction
E00-12/1 25 0 0 40
E00-12/3 100 100 100 100
E00-12/4 0 0 15 0
E00-12/5 0 0 10 0
E00-12/6 0 0 30 85
E00-12/7 0 0 0 39
E00-12/8 100 85 20 96
E00-12/11 0 0 10 70
E00-12/13 0 0 0 61
E00-12/14 0 0 0 0
E00-12/16 50 0 10 0
E00-12/21 0 0 15 0
E00-12/22 20 0 10 72
E00-12/24a 0 0 0 26
E00-12/25 0 0 10 10
E00-12/27 0 0 25 75
E00-12/31 0 0 15 0
E00-12/32 0 0 15 0
E00-12/36 10 0 5 0
E00-12/46 0 0 0 0
E00-12/51 0 0 5 0
2.1.3.1. Isolated compounds from the fungus Penicillium spp.
2.1.3.1.1. Oxaline (12, known compound)
Oxaline [Nagel et al., 1976] belongs to a group of mycotoxins which includes
meleagrin [Kawai et al., 1984], the glandicolins [Dictionary of Natural Products, 2000]
and the structurally-related roquefortines [Ohmomo et al., 1975] which are all
metabolites of Penicillium spp. (Fig. 2.40a). Mycotoxins are secondary metabolites of
fungi which are ubiquitous in a broad range of commodities and feeds, and are toxic
to mammals, poultry and fish. These compounds are characterized by having
interesting structural features, namely, an N-OH group, a dehydrohistidine unit, an
isoprenoid side chain, and a single carbon atom having three nitrogen functionalities. 
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Structure Elucidation
Compound 12 (Fig. 2.40b) was isolated as white scaly powder. It gave a molecular
ion peak at m/z 446 in (-)-ESIMS (Fig. 2.41). Its 1H NMR spectrum (Fig. 2.42) is
similar to that of oxaline isolated from cultures of the toxicogenic fungus Penicillium
oxalicum [Nagel et al., 1976]. Furthermore, a fragment ion at m/z 377 in the (-)-
ESIMS spectrum which represents the loss of the isoprenoid side chain is also typical
of oxaline and its derivatives [Ibid]. From the COSY spectra, an ABCD spin system
was observed from  the aromatic resonances at  δ 7.61(H-4), δ 7.29 (H-6), δ 7.09 (H-
5) and δ 7.00 (H-7). An exomethylene moeity also comprised an ABX system  at δ
5.97(H-22), δ 5.00 (H-23A), and δ 4.94 (H-23B). Two singlets at δ 3.65 and at δ 3.54
were assigned to two methoxyl groups H-27 and H-26, respectively. Two geminal
methyl groups gave a 6-proton singlet at δ 1.24. Two singlets were also observed
corresponding to signals from H-8 (δ 5.39) and H-15 (δ 8.10). To the imidazole
protons H-18 and H-20 were assigned the signals at δ 8.96 and 8.19.
The proton and carbon signals (Table 2.14) were assigned based on comparison
with literature data [Nagel et al., 1976; Konda et al., 1980] and confirmed by HMBC.
Observed C-H correlations are shown below (Fig. 2.43). 
The relative stereochemistry of compound 12 at the stereogenic centers C-2 and C-3
was also assumed to be identical with that reported in the literature, based on
similarities of the observed [α]D value of  -24o (c 0.168, MeOH)  with literature value
of –45o (c 0.3, MeOH) [Nagel et al., 1976; Konda et al., 1980].  
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Bioactivity
Oxaline has been considered as a mycotoxin [Lund and Frisvad, 1994; Steyn 1995;
Kozlovskii et al., 2000]. Roquefortine, a toxin which has been reported to affect the
central nervous system, has also been found to be the precursor in the biosynthesis
of oxaline [Reshetilova et al., 1995]. 
In bioassay screenings performed in the laboratory, oxaline has been found to be
active against Gram positive and Gram negative bacteria. At a loading concentration
of 50 µg, it inhibited growth of S. aureus, E. coli, B. subtilis and C. albicans by 7, 10,
10 and 15 mm, respectively.
No activity was observed against A. salina and P. littoralis.
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Table 2.14: NMR data of compound 12
C δ (lit) δ (Actual)* 1H 
2 101.6  s 101.4 s
3 52.6 s 53.0 s
3a 146.5 s 146.4 s
4 124.7 d 124.4 d 7.61 (d, 7.88)
5 123.3 d 122.8 d 7.09 (t, 7.57)
6 128.4 d 130.0 d 7.29 (t, 7.57)
7 112.0 d 111.8 d 7.00 (d, 7.88)
7a 146.6 s 147.3 s 
8 107.0 d 109.0 d 5.39 (s)
9 126.0 s 125.7 s
10 157.3 s 156.8 s
12 123.1 s 121.8 s
13 166.1 s 163.9 s
15 109.7 d 8.10 (s)
16 126.2 s
18 136.4 d 8.96 (s)
20 133.8 d 130.9 d 8.19 (s)
21 42.5 s 42.0 s
22 142.8 d 144.0 d 5.97 (m)
23 113.9 d 4.94 (d, 10.41)
5.00 (d, 17.02)
24 24.1 q 1.24 (s)
25 23.7 q 1.24 (s)
26 55.7 q 55.0 q 3.54 (s)
27 65.2 q 64.1 q 3.65 (s)
N-H 10.41 (s)
* obtained from HMBC spectra
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2.1.3.1.2. Griseofulvin (13, known compound)
Griseofulvin was first reported in 1939 from Penicillium griseofulvum [Oxford and
Simonart, 1939]. Since then, it has also been isolated from cultures of P. janczewskii,
P. patulum, P. albidum, P. raciborskii, P. melinii, P. urticae, P. raistrickii, P.
brefeldianum, P. viridi-cyclopium, P. brunneo-stoloniferum; P. janthinellum, P.
martensii, P. nigricans, P. urticae, Carpenteles, P. hordei brefeldianum, Nigrospora
oryzae, Nigrospora saccharii, Aspergillus versicolor [Antibase, 2002].
Structure Elucidation
The (+)-ESIMS spectrum of 13 (Fig. 2.44)  showed a molecular ion peak at 353-355
[M+H]+, corresponding to the molecular formula C17H1735ClO6. The 1H (Fig. 2.45) and
13C NMR spectra (Fig. 2.46) was identical with that of griseofulvin in the literature.
Two keto groups were evident, as well as four unsaturated carbons which resonated
in the low field region, indicating direct bonding with oxygens. Five signals were also
observed in the region between 90 to 104 ppm corresponding to four unsaturated
carbons and an sp3 quaternary carbon with a particularly deshielded nucleus from
direct bonding with an oxygen and a keto group. In the aliphatic region, three signals
corresponding to the three methoxyl carbons were also observed between 56 to 57
ppm. Only two remaining 13C signals at δ 36.8 and 14.3 were seen. However, the 1H
NMR showed the presence of a methyl group and three aliphatic protons which
exhibited a AMX three spin system, suggesting the presence of yet another carbon
overlapping with the DMSO peak. The assignment of cabon and proton signals
(Table 2.15) were based on comparison with literature data  [Sato, 1976; Levine et al,
1971].
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Fig. 2.44: (+)-ESIMS of compounds 13 (top) and 14 (bottom)
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Furthermore, an x-ray analysis of a single crystal of compound 13 (Fig. 2.47) found it
to be identical with griseofulvin as reported in the literature [Brown and Sim, 1963].
Optical rotation data obtained for compound 13 (αD=+315, c 0.410, CHCl3) was
similar to literature data (αD=+370, c 0.410, CHCl3) [ Grove et al., 1952].
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Fig. 2.47: Crystal structure of compound 13
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2.1.3.1.3. 7-Dechlorogriseofulvin (14, known compound)
Dechlorogriseofulvin was first isolated from Penicillium griseofulvum and P. janc-
zewskii in 1951 [MacMillan, 1951]. It has also been reported to be a product of the
cultures of P. urticae, P. nigricans, Aspergillus versicolor, Coriolus vernocipes
[Antibase, 2002].
Structure Elucidation
The UV and (+)-ESIMS (Fig. 2.44) spectra of compound 14 was similar with that of
13. Eluting 1.5 minutes earlier than griseofulvin in the RP-18 HPLC analytical system,
14 also exhibited a  shift in its UV absorption maxima from 292 to 288 nm when
compared with 13. It showed a molecular ion peak at m/z 319 corresponding to
[M+H]+ in (+)-ESIMS (Fig. 2.44) which was compatible with the molecular formula
C17H18O6 suggesting the loss a chloro group from griseofulvin. This was confirmed by
the 1H NMR (Fig. 2.45) which was similar with that of 13 except for an additional
aromatic proton which was meta-coupled with another aromatic proton (J =1.7)
(Table 2.15). 
The absolute configuration of compound 14 is also deduced to be identical with that
of dechlorogriseofulvin due to the similarity in their [α]D values [observed [α]D +191 (c
0.081, MeOH); lit. [α]D +390 (c 1.0, Me2CO) [Macmillan, 1951].
Results
71
Table 2.15: NMR data of compounds 13 and 14
13
13C 1H
14
1H 
1
2 91.0
3 191.2
3a 104.6
4 157.6
5 90.1 6.49 (s) 6.46 (d, 1.7)
6 164.5
7 95.2 6.21 (d, 1.7)
7a 168.6
2’ 170.3
3’ 104.0 5.59 (s) 5.57 (s)
4’ 195.6
5’ 40.5 2.66 (dd, 16.7,13.2) 2.66 (d, 14.1, 12.9)
2.34 (dd, 16.7, 4.7) 2.32 (dd, 14.1, 2.8)
6’ 36.8 2.79 (ddd, 6.6, 13.2, 4.7) 2.79 (m)
4-OCH3 57.1 3.93 (s) 3.83 (s)
6-OCH3 56.4 4.03 (s) 3.88 (s)
2’-OCH3 56.6 3.61 (s) 3.60 (s)
6’-CH3 14.3  0.79 (d, 6.6) 0.80 (d, 6.3)
Bioactivity
Griseofulvin is a widely used antifungal agent with affinity to keratin. It is also a
possible human carcinogen with LD50 of 1200 mg/kg. Dechlorogriseofulvin, on the
other hand, was reported to possess a much weaker antifungal activity against the
fungus Botrytis allii (6.25 µg/mL least concentration compared to griseofulvin’s 0.05
µg/mL) [MacMillan, 1951].
Compound 13 was found active against B. subtilis and C. albicans down to a loading
concentration of 1 µg, but not with S. aureus and E. coli (Table 2.16). When tested
against C. albicans at a concentration of 10 µg/disk in the agar diffusion test, no
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activity was exhibited by 14. Both compounds 13 and 14 were inactive in the brine-
shrimp lethality and insecticidal tests. 
Table 2.16: Agar diffusion assay data of compound 13
Zone of inhibition (mm)Concentration
(µg) S. aureus E. coli B. subtilis C. albicans
1 no activity no activity 7 15
5 no activity no activity 10 18
10 no activity no activity 10 15
2.1.3.1.4. Communesin B (15, known compound)
N
O
N
NN
H
O
3HC
CH3
CH3
H
H
H H
1
2
3
4
4a
8a
8
5
7
6 15
7a
12a
12
13
14
18
17
1"
2" 3"
4" 5"
6"
11 21
22
24
23
9
10
20
19
16
14a
R
                                      R = CH3,  compound 15 (communesin B)
                                      R = H,      compound 16 (communesin C)
                                      R = CHO, compound 17 (communesin D)
        Fig. 2.48: Isolated communesin congeners
Communesin B (Fig. 2.48) is a metabolite previously isolated from a strain of
Penicillium spp. which was associated with the marine alga Enteromorpha intestinalis
[Numata et al., 1993]. It was isolated with a congener, communesin A, possesssing
an acetyl group attached to N-16. Both compounds were reported to exhibit
moderate to potent  cytotoxic activity in the P-388 lymphocytic leukemia test system
in cell culture (ED50 3.5 and 0.45 µg/ml for communesin A and B, respectively) [Ibid].
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Structure Elucidation
Compound 15 (Fig. 2.48) showed a molecular ion peak at m/z 509 in the (+)-in
ESIMS (Fig. 2.52A) which is compatible with the molecular formula C32H36N4O2. The
fragmentation pattern of the molecular ion of 15 showed the presence of an ion
corresponding to [M+H-71]+ which could be due to the loss of the dimethylethoxide
moeity. This fragment ion were later found to be present in the ESIMS spectra of the
other communesin congeners, compounds 16 and 17 (Fig. 2.52b and 2.52c). The 13C
(Fig. 2.49) and 1H (Fig. 2.52) of 15 agreed with the NMR data of  communesin B as
reported in the literature [Ibid]. 
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Fig. 2.49: 13C NMR spectra of compound 15
The assignment of 13C and 1H NMR signals was established by HMQC and the C-H
connectivities were confirmed by HMBC (Table 2.17). Some of the important
correlations are shown below (Fig. 2.50a). 
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Fig. 2.50a: Important HMBC correlations in the spectra of compound 15
It is interesting to point out that the observed [α]D value of 15 which was –58o (c, 0.1,
MeOH) is identical with that of the reported value of communesin A (-58o c 0.14,
CHCl3), the N16-acetyl congener of communesin B, but deviates from the reported
value of communesin B (+8, c 0.23, CHCl3) [Numata et al., 1993]. Although the
absolute configurations of the stereogenic centers of communesins A and B in the
literature were not determined [Ibid], the identical relative stereochemistry and [α]D
values of 15 and communesin A attest to their identical absolute configuration.
However, no conclusion can be drawn on the relationships of 15 and communesin B
except that the two have the same relative stereochemistry at all their stereogenic
centers except at C-21 as gathered from a ROESY experiment on 15. The
stereochemistry at C-21 could not be deduced from the ROESY spectra and could be
the differing point in the stereochemistries of 15 and communesin B. Observed
NOE’s are shown below (Fig. 2.50b).
NN
NN
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CH3
CH3
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H
Fig. 2.50b: Important NOEs found in the ROESY spectra of compound 15
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2.1.3.1.5. Communesin C (16, new compound)
HREIMS m/z 494.2668 (calcd for C31H34N4O2, 494.2682)
[α]D -30 (c 0.038, MeOH)
Compound 16 and 17 (Fig. 2.40) exhibited similar UV spectra as 15 (Fig. 2.51).
Compound 16 gave a base ion peak at m/z 495 in (+)-ESIMS (Fig. 2.52B) which is 14
amu less than 15. Its molecular formula was established by HREIMS to be
C31H34N4O2. Moreover, as with 15, the mass spectra also showed a strong ion peak
at m/z 424 corresponding to [M+H-71]+ possibly due to the loss of the
dimethylethoxide moeity. The 1H NMR spectra of 16 (Fig. 2.53) also was almost
identical with that of 15 (Table 2.17). The difference lies only in the absence of the N-
methyl group which is seen at δ 2.78 in 16. Slight  shifts of the H-6 and of the
aromatic H-14 signals to lower fields were also observed in 16. The COSY spectrum
(Fig. 2.54) showed that all the spin systems found in 15 were retained in 16. Hence it
is postulated that the new derivative 16, to which the name communesin C is
assigned, is the N-demethyl derivative of communesin B.
The stereochemistry of compound 16 is assumed to be identical with that of 15 due
to the similarity in their observed [α]D values [-30 (c 0.038, MeOH) for 16 and –58 (c
0.1, MeOH) for 15].
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Fig. 2.51: UV spectra of the compounds 15-17
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Fig. 2.52: (+)-ESIMS spectra of compounds 15 (A), 16 (B), and 17 (C)
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Fig. 2.53: H NMR spectra of compounds 15 (A), 16 (B), and 17 (C)
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formyl group. The EIMS spectra of 17 (Fig. 2.56) also showed an ion peak at m/z 451
corresponding to [M-71]+. which repeated this observation that the loss of the
dimethylepoxide moiety is characteristic in the fragmentation patterns of these
compounds.
Fig. 2.56: EIMS of compound
The 1H and  the 2D NMR (COSY, ROESY and HMB
established its structure as the formamide derivative of c
The 1H NMR spectrum of 17 was also highly similar to
The most prominent difference is the loss of the H-1’
present in 15. Furthermore an additional proton signal a
corresponding to a formyl proton. The H-6 signal was 
δ 5.55 compared to that of 15 which resonated at δ 4
greater deshielding effect of the amide moeity in 17. Th
showed that all the spin systems found in 15 and 16 are
changes in the resonances of the olefinic protons from t
two separate N-ethylene moeities, the alkyl epoxide mo
H-1 to H-4. However, it was observed that the doubl
protons H-12 and H-14 from the other aromatic ring 
(Table 2.17), probably due to the resonance-enhanced 
the formamide group. 
+[M]+[M-71] 17
C) spectra of the compound
ommunesin B (Table 2.17).
 both 15 and 16 (Fig. 2.53).
 signal at δ 2.78 which was
t δ 8.70 was observed in 17,
also seen at a lower field at
.65, presumably due to the
e COSY spectrum (Fig. 2.55)
 also retained: there were no
he conjugated side chain, the
eity and the aromatic protons
et signals from the aromatic
were shifted to lower fields
electron-withdrawing effect of
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An interesting feature in the NMR spectra of 17 in DMSO-d6 (Fig. 2.53c) showed the
presence of two stereoisomers of this compound due to the differences in the
orientation of the N-formyl group. DMSO-d6 allowed the slow interconversion of the
two isomers which caused the appearance of two signals of the protons of the formyl
group as well as those of NH, and H–14 which resonated at different chemical shifts
due to the deshielding effect of the formyl carbonyl. This was again evident in the
COSY spectra of 17 which showed correlations between NH-A with H-6B and
between NH-B with H-6B. The ROESY spectra of 17 also showed correlations
between the CHO-A with H-14B and between CHO-B with NH-A and NH-A. The two
stereoisomers are shown in Fig. 2.57 with important NOE’s from the ROESY spectra.
The relative stereochemistry of 17 was found to be identical with 15, as deduced
from its ROESY spectrum. Important correlations are shown below (Fig. 2.57). Its
[α]D value of +23.3o c 0.039, MeOH) however deviates from 15 and is more related to
that of communesin B in the literature (+8, c 0.23, CHCl3) [Numata et al., 1993]. The
HMBC spectra confirmed the proposed structure which showed correlation between
both the formyl proton and H-13 with C-14a. Important correlations are shown below
(Fig. 2.58).
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Fig. 2.55: COSY spectra of compound 17
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Fig. 2.57: Important NOEs found in the ROESY spectra of compound 17
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Table 2.17: NMR data of the compounds 15-17 measured at 500 Mhz
15 15 16 17 17
C# 1H
DMSO-d6
13C
MeOD
1H
DMSO-d6
1H
DMSO-d6
13C*
DMSO-d6
1 6.57 120.62 6.57 6.64 120.0
2 6.79 118.06 6.7 6.79 120.0
3 6.92 128.41 6.9 6.95 129.0
4 6.57 123.81 6.57 6.67 120.1
4a 145.31 142.3
6 4.65 83.45 4.83 5.50 76.4
7 52.56 51.1
7a 133.63 135.5
8 53.45 53.6
8a 133.42 131.5
9 5.14 80.50 5.12 5.24 80.0
11 4.20 66.80 4.18 4.39 64.6
12 6.04 114.10 6.1 6.64 139.5
12a 137.50 138.8
13 6.79 129.93 6.74 7.04 132.0
14 5.92 102.77 6.03 7.60 107.4
14a 152.30 141.0
17 2.73 45.44 2.78 2.79
3.72 3.73 3.76
18 1.74 31.52 1.67 1.78
2.73 2.78 2.79
19 2.12 38.94 2.09 2.19
2.31 2.27 2.43
20 3.20 37.14 3.2 3.20 35.8
3.30 3.3 3.30
21 2.90 65.59 2.88 2.92 63.5
22 61.59 60.0
23 1.32 25.00 1.32 1.33 24.9
24 1.56 20.79 1.55 1.61 20.5
1' 2.78 29.88
1" 170.47 167.2
2" 6.50 122.36 6.53 6.52 122.0
3" 7.06 143.12 7.07 7.08 144.7
4" 6.14 131.91 6.16 6.17 131.1
5" 6.14 138.81 6.16 6.17 137.0
6" 1.82 18.80 1.81 1.83 50.7
NH 4.32 br s 5.59
HC=O 8.70
*obtained from HMBC spectrum
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Bioactivity: 
Compound 15 showed strong activity against A. salina, S. littoralis, and the human
leukemia cell lines. It was also active against S. aureus, B. subtilis and C. albicans
with a minimum loading concentration of 0.5 µg, but not against E. coli. (Table 2.18-
2.21).
Table 2.18: Agar plate diffusion assay of compound 15.
Zone of inhibition (mm)Concentration
(µg/disk) S. aureus E. coli B. subtilis C. albicans
0.5 10 n.a 9 12
2.5 10 n.a 9 12
5 10 n.a 10 15
Table 2.19: Brine-shrimp lethality test for compounds 15-17
Mortality (%)Concentration
(µg/mL) 15
LC50 = 0.300
16
LC50 = 1.933
17
LC50 = 0.567
0.0 0 0 0
0.2 10 0 0
0.4 50 0 0
0.6 100 0 0
0.8 100 10 40
1.0 100 25 100
2.0 100 50 100
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Table 2.20: Insecticidal test for compound 15 (LC50 = 6.9 ppm)
Concentration
(ppm)
Mortality (%)
0 0
5 50
15 80
20 80
50 100
Table 2.21: Cytotoxicity tests for compound 15
Concentration
(µg/mL)
Growth rate (%) in different cell lines
JURKAT+
EC50 = 6.159
THP-1 *
EC50 = 14.23
MM-1§
EC50 = 7.918
0 100.0 100.0 100
1 89.3 86.0 93.0
2.5 92.0 - 92.3
5.0 67.0 90.0 87.0
10 31.8 86.0 43.7
20 25.0 - -
25 1.7 10.0 5.3
50 2.0 - -
+values taken from two separate MTT assays and two separateThy assays.
* values taken from MTT assay 
§ values taken from both MTT and Thy assays 
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2.1.3.2. Isolated compounds from an unidentified fungus derived from the
sponge Axinella verrucosa
Monocerin (18, known compound)
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Fig. 2.59: Structure of compound 18
Monocerin was originally isolated from Helminthosporium monoceras [Aldridge,
1970]. It has since been reported to be a product of cultures from the fungi Fusarium
larvarum, Drechslera ravenelli, Drechslera turcicum and Readeriella mirabilis
[Dictionary of Natural Products on CD-ROM, 2002]. 
Structure Elucidation
Compound 18 (Fig. 2.59) gave a molecular ion peak at m/z 308 by EIMS (Fig. 2.60).
This molecular mass was compatible with the molecular formula C16H20O6. The 13C
(Fig. 2.61) and DEPT showed sixteen carbons: one carboxyl, five substituted
aromatic carbons, one unsubstituted aromatic carbon, two methoxyls, three oxagen-
bound methines, three methylenes and one methyl. Assignment of one bond C-H
connectivities was established by HMQC. The COSY showed that H-11 coupled  with
H-4, which was connected to a diastereotopic methylene H-3A and H-3B. These two
geminal protons were also seen to correlate with the methine proton H-2, which was
further connected to the methylene protons H-12. H-12 was was seen to be attached
to H-13 and H-14 in a side chain. Two-bonds and three-bonds C-H connectivities
were established by HMBC. NMR data of 18 are presented in Table 2.22).
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Fig. 2.60: EIMS spectra of compound 18
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Further proof of the proposed structure was supplied by the fragmentation  pattern in
EIMS. A strong ion peak at m/z 265 (40%) due to the loss of the n-propyl side chain
was observed. Further fragment ion at m/z 247 represents a further loss of a hydroxyl
group.
The stereochemistry at the three stereogenic centers are believed to be identical with
monocerin. The coupling constant of 2.81 Hz between H-4 and H-11 indicate a cis
configuration between these protons, mirroring that of monocerin. Measured [α]D
values of monocerin + 51 (c 0.144, MeOH) was almost identical with literature data of
[α]D +53 (c 0.85, MeOH) [Aldridge and Turner, 1970]. Monocerin has been reported
as having an absolute stereochemistry 2S, 4R 11R, as established through
chiroptical and 1H NMR analysis, and confirmed by synthesis [Grove and Pople,
1979; Mori and Takaishi, 1989].
Table 2.22: NMR data of compound 18
C 13C 1H HMBC
2 83.5 4.12 (m)
3A 40.5 2.64 (ddd, 14.5, 8.83, 6.31) C12, C4, 
3B 2.02 (br dd, 14.5, 5.68) C12, C4, C2, C11
4 80.2 5.10 (br dd, 5.68, 2.81) C2, C11
6 169.9
7 157.3
7a 105.0
8 160.6
9 138.6
10 106.6 6.77 (s) C11, C7a, C10a, C8, C7, C9, C6
10a 133.8
11 76.1 4.63 (d, 2.81) C4, C7a, C10, C10a
12 39.8 1.60 (m) C14, C13, C3, C4
13 20.6 1.40 (m) C14, C12
14 14.7 0.92 (t, 7.36) C13, C12
15 61.4 3.94s) C9
16 57.3 3.82 (s) C8
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Bioactivity
Monocerin was first reported as a toxin isolated from Helminthosporium monoceras
[Aldridge and Turner, 1970]. It was found to be active against powdery mildew on
wheat. It has also been found to be a metabolite of the entomogenous fungus
Fusarium larvarum Fuckel and was found to possess insecticidal activities.
Furthermore, monocerin isolated from an American Exserohilum turcicum derived
from Sorghum hapelense, exhibited phytotoxicity. A French strain of the fungus
Exserohilum turcicum isolated from maize, also yielded monocerin, which gave
phytotoxic properties [Cuq et al., 1993]. It caused necrotic lesions on punctured
leaves, the size of which is in direct relation with the dose applied. It also inhibits the
root growth of pregerminated seeds: the median dose (ID50) being around 10-3 M. It
decreased the viability of maize root cap cells and mesophyll protoplast suspensions:
the ID50 was 2.5 – 5 x 10-4 M for cells and around 8 x 10-5 M for protoplasts [Ibid]. 
Compound 18 was found to be active against S. aureus, B. subtilis and C. albicans
with zones of inhibition of 10, 10 and 15 mm, respectively, using a concentration of
50 µg/mL. It was also found to be an potent antifeedant of the polyphagous insect S.
littoralis exhibiting ED50 of 14 ppm. It was inactive in the brine-shrimp lethality test.
2.1.4. Isolated compound from Aspergillus flavus, Link: Fries derived from
Hyrtios aff. reticulatus
The extracts obtained from 14 various cultures of fungal strains collected from
different species of Philippine sponges were initially screened for biological activity.
Results of the screening (Fig. 2.62a) led to the selection of the extract of Aspergillus
flavus associated with the sponge Hyrtios aff. reticulatus, which showed 95%
mortality rate in the brine-shrimp lethality test, 25% growth rate in the insecticidal test.
It also showed activities in the animtimicrobial assay (Table 2.23a). 
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α-Cyclopiazonic acid (19, known compound)
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(19) a-Cyclopiazonic acid
Fig. 2.62b: Structure of compound 19
This toxic alkaloid was first isolated from Penicillium cyclopium Westling in 1968
[Holzapfel, 1968]. This known mycotoxin appears to be produced mainly by
Penicillium camemberti, Penicillium commune, Penicillium griseofulvum, Aspergillus
versicolor, Aspergillus flavus and Aspergillus oryzae [Dictionary of Natural Products
on CD-ROM, 2002]. 
Compound 19 (Fig. 2.62b) gave a molecular ion peak at m/z 337 [M+H]+ in the
positive ion ESIMS spectrum which is compatible with the molecular formula
C20H20N2O3.  The 1H and 13C NMR (Fig. 2.63) matched that of α-cyclopiazonic acid in
the literature [Nolte et al., 1979]. 
The COSY spectra showed three separate spin systems. The indole proton at δ 10.7
was seen to couple to its neighboring proton H-10. The three aromatic protons at
δ 6.76, δ 6.98, and δ 7.13 exhibited an ABC system. H-15 at δ 6.76 was ortho-coupled
(J = 8.2) to proton H-14 at δ 6.98, which is furthered ortho-coupled to H-13 at δ 7.13
(J = 6.9). The third spin system presented an XMA2B system [Holzapfel, 1968]. H-5
at δ 3.70 coupled with H-8 at δ 3.41 with a magnitude of 11.03 Hz indicating an anti-
configuration. H-8 further coupled with H-19 at δ 2.38 with a magnitude of 5.65 Hz
which suggests a cis-configuration. H-19 also showed coupling with geminal protons
(H-18A and B) centered at δ 2.90 and 2.96. The relative configuration of these three
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stereogenic centers C-5, C-8 and C-19 as derived from the coupling constants of the
attached protons are identical the reported relative configuration of α-cyclopiazonic
acid [Holzapfel, 1968]. The similarities in the [α]D values of compound 19 (-122o, c
0.0214, MeOH) and α-cyclopiazonic acid (-109.4o, c 0.885, CHCl3) [Pohland et al.,
1982]] proved that the two compounds are identical.
The assignments of the 13C and 1H signals (Table 2.23b) were based on comparison
with literature data. The proposed structure was corroborated by HMBC.
Bioactivity
α-Cyclopiazonic acid is a toxin, the oral administration of which to male and female
rats proved fatal after one to five days, and gave LD50 values of 36 and 63 mg kg-1,
respectively [Purchase, 1971]. In rats, cyclopiazonic acid produces degenerative
changes and necrosis in the liver, pancreas, spleen, kidney, salivary glands,
myocardium, and skeletal muscle. Although the teratogenic potential proved to be
low in rats [Morrissey, et al., 1984], significant retardation in embryonic skeletal
development was evident after administration of 5-10 mg of cyclopropiaqzonic acid
during pregnancy. When chicken were fed rations containing 100 mg kg-1
cyclopropiazonic acid for seven weeks, the test group experienced decreased weight
gain, poor feed conversion, and a sixfold increase in mortality compared to chickens
receiving toxin-free feed [Dorner, 1983]. Postmortem examination revealed
proventricular lesions characterized by mucosal erosion and hyperemia, and yellow
foci in the livers and spleens. The birds also experienced mucosal necrosis in the
gizzard, and hepatic and splenetic necrosis and inflammation.
It also inhibits sarcoplasmic reticulum Ca2+-ATPase and ATP-dependent Ca2+
transport and is used as a pharmacologic tool for studying intracellular Ca2+
homeostasis [Dictionary of Natural Products on CD-ROM, 2002].
Compound 19 showed antimicrobial activity in the agar plate diffusion assay with 50
µg/disk causing zones of inhibition of 10 mm against each of the organisms S.
aureus, B. subtilis and C. albicans. It also showed antifeedant activity against S.
littoralis with ED50 of 10.08 ppm. 
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Table 2.23b: NMR data for compound 19 (DMSO-d6 in 500MHz)
13C 1H HMBC
2
3 140.0
4 195.2
5 69.0 3.70 (d, 11.03) C4, C8, C9
6 192.0
7 25.4 2.24 (s) C3, C6
8 36.1 3.41 (dd, 10.72, 5.65) C4, C5, C9, C10, C17, C18, C19
9 110.1
10 121.2 7.04 (d, 1.89) 
N-H 10.7 (s) C9, C10, C12, C17
12 133.1
13 108.5 7.13 (d, 8.2) C14, C15, C17
14 121.7 6.98 (dd, 8.2, 6.9) C13, C15, C16, C12
15 115.3 6.76 (d, 6.9) C9, C12, C17
16 129.0
17 126.0
18 26.3 2.90 (dd, 15.77, 11.98) C8, C15, C16, C17, C19
2.96 (dd, 15.77, 5.65)
19 52.9 2.38 (ddd, 11. 98, 5.65, 5.65) C5, C8, C9, C18
20 61.5
21 25.3 1.50 (s) C19, C20, C22
22 25.3 1.49 (s) C19, C20, C21
2.2. Secondary metabolites isolated from sponges
2.2.1. Isolated compounds from Agelas Nakamurai
Sponges belonging to the genus Agelas have been found to be rich sources of
bromopyrrole alkaloids. This group of alkaloids is represented by oroidin (Fig. 2.64a)
which was first isolated in 1971 from Agelas oroides [Forenza et al., 1971].
Subsequently, many other species of Agelas, Axinella, Acanthella, Hymeniacidon,
Phakellia, and Pseudaxinyssa and Halichondria [Walker et al., 1981; Nakamura et
al., 1984; Gunasekera et al., 1989; Cafieri et al., 1997] have been reported to contain
high levels of oroidin and/or its cyclic analogues. Therefore, the oroidin alkaloids are
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useful chemotaxonomic markers for axinellid sponges that were once allied with the
Agelasida [Hao et al., 2001]. Oroidin and 4,5-dibromopyrrole-2-carboxylic acid were
discovered to be responsible for the chemical defense of Agelas clathrodes and five
other species of Agelas from tropical Caribbean coral reefs [Chanas et al., 1996).
This group of compounds exhibits interesting bioactivities such as insecticidal,
antimicrobial, Na, K-ATPase inhibitory, and antiserotonergic activities. Sceptrin (Fig.
2.64a) and its analogues exhibited potent antibacterial/antifungal [Bernan et al.,
1993] activities, anti-muscarinic activity [Rosa et al., 1992], and anti-histaminic
activity [Cafieri et al., 1997]. Furthermore, oxysceptrin is also a potent actomyosin
ATPase activator [Kobayashi et al., 1991].
The total extract from the sponge Agelas nakamurai showed antimicrobial activity
(Table 2.24a). Upon chemical investigation of the extract, compounds 20-24 (Fig.
2.64b) were isolated, with 4-bromopyrrole 2-carboxamide (20) and 4-bromopyrrole 2-
carboxylic acid (21) as the major compounds. This was the first time that compound
21 was isolated from a natural source.
Table 2.24a: Antimicrobial assay result of the extract of Agelas nakamurai
Test
Microorganism
B.
subtilis
S.
aureus
E.
coli
C.
albicans
Zone of
Inhibition (mm)
25 22 15 25
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Fig. 2.64b: Metabolites from Agelas nakamurai
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2.2.1.1. 4-bromopyrrole 2-carboxamide (20, known compound)
4-bromopyrrole 2-carboxamide has been previously isolated from the sponge
Acanthella carteri Dendy, 1889 (Acanthella aurantiaca Keller, 1889) [Mancini et al.,
1997] and was reported to exhibit activity against NSCLC-N6 human non-small-cell-
lung carcinoma, recording IC50 of 9.4 µg/ml [Ibid]. Its isomer, 5-bromopyrrole
carboxamide, which showed antimicrobial activity against Gram-positive bacteria and
fungi [Iwagawa et al., 1998] has been isolated from Agelas nakamurai [bid]. 4,5-
Dibromopyrrole 2-carboxamide has been originally isolated from Agelas oroides
[Forenza et al., 1971] and subsequently in Agelas mauritiana [Tsukamoto et al.,
1996b] and showed antifouling activity against the ascidian Ciona savignyi at a
concentration of 2.5 µg/mL [Ibid].
The structure of compound 20 (Fig. 2.64b) was established through EIMS (Fig. 2.65),
1H (Fig. 2.66), and 13C NMR data (Fig. 2.67) and by comparison with literature data
[Mancini et al., 1997]. NMR data are presented in Table 2.24b.
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C5H479BrNO2 (188.94232; expected 188.9425 calc for C5H479BrNO2).The 1H NMR
spectrum was similar to that of the amide except for a broad signal at 11.5 ppm due
to the carboxyl proton (spectra not shown). The 13C NMR spectrum also showed that
the pronounced difference was the upfield shift of the C-2 signal due to the greater
shielding effect of the carboxylic group, whereas a downfield shift was observed for
C-5 which might be due to the resonance-stabilized electron-withdrawing effect of the
carboxylic substituent. 
Table 2.24b: 13C and 1H NMR data of compounds 20 and 21 measured with
DMSO-d6 at 500 MHz
13C 1H 
20 21 20 21
1 11.5 (br s)
2 127.2 125.0
3 123.1 124.2 6.84 (d, 1.6) 6.83 (d, 1.6)
4 97.5 97.8
5 114.2 117.6 6.95 (d, 1.6) 6.97 (d, 1.6)
6 164.6 163.4
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Fig. 2.67: 13C NMR of compounds 20 (top) and 21 (bo
2.2.1.4. Mukanadin B (22, known compound)
The (+)-ESIMS (Fig. 2.68) showed pseudomolecular ion peaks at m
[M+H]+ which is compatible with the molecular formula C11H12BrN4O
NMR spectra (Fig 6.69) are superimposable with that of mukanadin 
isolated from the same sponge species [Uemoto et al., 1999].
presented in Table 2.25.
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Table 2.25: NMR data of compound 22
13C H
1 11.80 (s)
2 126.8
3 111.3 6.81 (dd, 2.52, 1.89)
4 94.8
5 121.1 6.96 (dd, 2.8, 1.6)
6 159.6
7 8.17 (t, 5.8)
8 37.6 3.23 (dt, 6.6, 5.8)
9 26.8 2.36 (dt, 7.6, 6.6)
10 108.8 5.53 (t, 7.6)
11 131.2
12 164.2
13 10.15 (s)
14 154.8
15 10.95 (s)
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Table: 2.26: NMR data of compound 23 in DMSO-d6 measured at 500 MHz
13C 1H
1 6.75 (d, 5.68)
2 124.5
3 113.1 6.63 (d, 1.90)
4 96.0
5 121.6 7.16 (d, 1.90)
6 157.9
7 7.73 (br s)
8A 46.0 3.59 (ddd, 13.2, 3.3, 1.7)
8B 3.30 (under HDO signal)
9 74.3 5.57 (br d, 3.79)
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Bioactivity
Compound 20, 21 and 23 showed moderate antimicrobial activities while compound
22 was inactive (Table 2.27). Compounds 20-24 exhibited no activity in the
insecticidal, brine-shrimp lethality and cytotoxicity tests.
Table 2.27: Agar plate diffusion assay of compounds 20, 21, and 23.
Concentration
(µg/disk)
Zone of inhibition (mm)
Compound 20 S.A E.C. B.S. C.A
5 n.a. n.a. n.a 12
10 8 12 10 12
50 10 10 12 15
Compound  21
5 n.a. n.a. 10 15
10 8 10 10 15
50 10 12 10 15
Compound 23
5 n.a. n.a. 10 10
10 n.a. n.a. 11 12
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2.2.2. Isolated compounds from Jaspis splendens
1
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b r in e -s h r im p  m o r ta lity  ra te  (0 .5  m g )
b r in e -s h r im p  m o r ta lity  ra te  (0 .0 5  m g )
in s e c t m o r ta lity  ra te
From 23 sponge extracts screened mainly for activity against brine-shrimp, the ethyl
acetate extract of the sponge Jaspis splendens exhibited strong activities in the
brine-shrimp lethality tests with mortality rates of 100% (0.5 mg extract) and 100%
(0.05 mg extract) and 50% mortality rate in the insecticidal test (Fig. . Upon chemical
investigation, the main component, jaspamide (jasplakinolide) (compound 24) was
isolated, together with trace amounts of its known derivatives, jaspamide B
(compound 25) and jaspamide C (compound 26) (Fig. 2.72). All three compounds
were observed to possess nearly identical UV spectra (Fig. 2.73). The HPLC
chromatogram of the extract containing the three compounds also showed that
jaspamide B and C were more polar than jaspamide (Fig. 2.73). Compounds 25 and
26 differ from 24 only in the polypropionate moeity, with the tripeptide portion of
jaspamide retained unaltered in both derivatives.
2.2.2.1. Jaspamide / Jasplakinolide (24, known compound)
This bioactive depsipeptide was first isolated by two independent groups from the
sponge Jaspis cf. Johnstoni in 1986 [Zabriskie et al., 1986; Crews et al., 1986]. Since
then, the presence of jaspamide in other sponge genera, including Auletta cf.
Jaspis splendens
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Constricta [Crews et al., 1994] and Hemiasterella minor [Talpir et al., 1994] has also
been reported. 
Jaspamide represents a new class of cyclic depsipeptides. It contains a propionate
unit and two rare amino acids, β-tyrosine previously reported in the edeine peptides
and 2-bromoabrine which is apparently a new amino acid [Zabriskie et al., 1986].
The data (Table 2.29) from the (+)-ESIMS (Fig. 2.74), 1H (Fig. 2.75) and 13C (Fig.
2.76) NMR spectra of 24 matched that of jaspamide [Zabriskie et al., 1986; Crews et
al., 1986]. Its [α]D value of + 65.8 (c 0.496, CHCl3) matched that of jaspamide (+65, c
1.535, CHCl3) [Zabriskie, et al., 1986] which has an absolute configuration of 2S, 6R,
8S, 11R, 13R, 15S as determined hydrolysis, chemical derivatization and chiral
HPLC of the alanine moeity and by X-ray crystal analysis of the acetate derivative of
jaspamide.
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Fig. 2.73: HPLC chromatogram with corresponding UV spectra
 of compounds 24-26
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Fig. 2.74: (+)-ESIMS spectra of compounds 24 (A), 25 (B), and 26 (C)
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Fig. 2.75: 1H NMR spectra of compounds 24 (A), 25 (B), and 26 (C)
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Fig. 2.76: 13C NMR spectra of compound 24
2.2.2.2. Japamide B (25, known compound )
Jaspamide B and C have been isolated from the sponge Jaspis splendas collected in
Vanuatu [Zampella et al., 1999]). Both compounds were reported to inhibit the in vitro
growth of th NSCLC-N6 human tumor cel lines with EC50  values in the µg/mL range
[Ibid].
Structure elucidation
Compound 25 was isolated as a white amorphous powder. It showed
pseudomolecular ion peaks at m/z 745-747 [M+Na]+ in (+)-ESIMS (Fig. 2.74),
indicating a molecular weight which is 14 amu more than that of 24. The 1H and
COSY (Fig. 2.77) spectra matched that of Jaspamide B as reported in the literature
[Zampella et al., 1999]. When compared with that of 24, the 1H NMR spectrum (Fig.
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2.75) of compound 25 showed the absence of the olefinic carbon-bound methyl H-35
which had appeared as a singlet at δ 1.58 in 24. Instead, two olefinic protons which
both appeared as singlets were observed at δ 5.83 and 6.14. Furthermore, the COSY
spectrum of 25 (Fig. 2.77) also indicated that the signal corresponding to the olefinic
proton H-5 in 24 was also missing. Thus, compared to 24, compound 25 showed a
shortened spin system encompassing the polyproprionate moeity: H-33 correlated
with H-8, which correlated with H-7A and H-7B. These geminal protons further
coupled with H-6, which in turn coupled  with the methyl H-34.
Moreover, the resonances of H-3A, H-3B, H-6, H-7, and H-8 were also shifted to
lower fields (Table 2.28). These features in the NMR data of the 25 are compatible
with the structure of jaspamide B. 
Stereochemistry
The absolute stereochemistry of jaspamide B in the literature was not determined
whereas its relative stereochemistry was assumed to be similar to that of jaspamide
due to the similarities in the 1H and 13C NMR chemical shifts observed for the
tripeptide portion of jaspamide and jaspamide B [Zampella et al., 1999]. Compound
25 showed similar [α]D value (+20, c 0.05, CHCl3) with that of jaspamide B (+11.4, c
0.0014, CHCl3) indicating that the two are probably the same compound.
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Fig. 2.77: COSY spectra of compound 25
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2.2.2.3. Jaspamide C (26, known compound)
Compound 26 showed pseudomolecular ion peaks at 725 and 727 in (+)-ESIMS (Fig.
2.74), two mass units more than 25. The presence of an ion peak at m/z 708 and 709
in the (+)-ESIMS spectra, which could be due to an [M+H-OH]+ ion, was not apparent
in the fragmentation patterns of 24 and 25, suggesting the possible presence of a
hydroxyl group in 26. Its 1H NMR spectrum (Fig. 2.75) gave proofs to this claim. The
presence of two singlets at 5.09 and at 4.99 ppm suggested that the exomethylene
protons (C-35) found in 25 were retained. Furthermore, a signal at δ 3.88 confirmed
the presence of the expected methine H-5. The hydroxyl group at C-5 was confirmed
by the 13C spectra which showed an additional oxygen bound sp3 carbon at  78.9
ppm (Table 2.30). The 1H NMR data of compounds 24-26 are presented in Table
2.28. The COSY spectrum of 26 (Fig. 2.78) showed that all spin systems in 25 are
retained. The HMBC spectrum showed correlations between the methyl protons H-
34, as well as the exomethylene protons H-35A and H-35B, with this carbon. It was
therefore assigned as C-5. Further key correlations found in the HMBC spectra are
shown below (Fig. 2.79).
Stereochemistry
Like jaspamide B, the stereochemistry of jaspamide C in the literature was not
established. Compound 26 exhibited an [α]D value of +9.0168 (c 0.168, MeOH) which
was related to that of jaspamide C [+25.4 (c 0.0013, CHCl3)] [Zampella et al., 1999]
which indicate that the two may have the same stereochemistry.
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Fig. 2.78: COSY spectra of compound 26
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Table 2.28: 1H NMR data of jaspamide and derivatives.
Jaspamide Jaspamide B Jaspamide C
1
2 2.65 (m) 2.58 (m) 2.52 (q, 6.9)
3 2.30 (m) 2.51 (dd, 12.5, 3.3) 2.28 (dd, 15.3, 6.9)
2.19 (dd, 15.2, 11.7) 2.27(dd, 12.5, 11.7) 2.18 (dd, 15.3, 6.9)
4
5 4.85 (HDO peak) 3.86 (d, 5.3)
6 1.93 (m) 3.30 (MeOD peak) 1.62 (m)
7 1.50 (ddd, 13.3, 9.8, 6.0) 2.10 (ddd, 14.5, 8.5, 6.9) 1.62 (m)
1.19 (ddd, 13.3, 8.2, 5.4) 1.41 (ddd, 14.5, 6.9, 5.1) 1.17 (m)
8 4.69 (m) 4.85 (HDO peak) 4.85 (HDO peak)
9
10 2.73 (dd, 15.5, 4.0) 2.74 (d, 8.2) 2.94 (dd, 16.1, 7.9)
2.65 (dd, 15.5, 8.5) 2.74 (d, 8.2) 2.74 (dd, 16.1, 6.3)
11 5.25 (dd, 8.5, 4.0) 5.21 (dd, 7.3, 5.9) 5.09 (dd, 12.0, 5.7)
12
13 5.66 (dd, 9.8, 6.9) 5.59 (dd, 9.5, 6.9) 5.59 (dd, 10.0, 6.3)
14
15 4.69 (q, 6.6) 4.64 (q, 6.6) 4.40 (q, 6.6)
16 0.72 (d, 6.6) 0.77 (d, 7.0) 0.79 (d, 6.9)
17 3.09 (s) 3.09 (s) 3.12 (s)
18 3.22 (dd, 14.8, 6.9) 3.30 (MeOD peak) 3.30 (MeOD peak)
3.16 (dd, 14.8, 9.8) 3.11 (dd, 14.8, 9.5) 3.10 (m) 
19
20
21 7.24 (d, 7.9) 7.25 (d, 7.9) 7.50 (d, 8.2)
22 7.07 (t, 7.9) 7.07 (t, 7.9) 7.06 (t, 8.2)
23 6.99 (ddd, 8.2, 7.9, 1.0) 6.97 (dd, 8.2, 7.9) 6.98 (m) 
24 7.53 (d, 8.2) 7.52 (d, 8.2) 7.50 (d, 8.2)
25
26
27
28 6.94 (br d, 8.5) 6.93 (d, 8.5) 6.98 (d, 8.5)
29 6.66 (d, 8.5) 6.66 (d, 8.5) 6.67 (d, 8.5)
30
31 6.66 (d, 8.5) 6.66 (d, 8.5) 6.67 (d, 8.5)
32 6.94 (br d, 8.5) 6.93 (d, 8.5) 6.98 (d, 8.5)
33 1.06 (d, 6.3) 1.16 (d, 6.3) 1.06 (d, 7.9)
34 0.84 (d, 6.6) 1.02 (d, 6.7) 0.82 (d, 6.6)
35 1.58 (s) 6.14 (s) 5.04 (s)
5.83 (s) 4.94 (s)
36 1.06 (d, 6.9) 1.10 (d, 7.0) 1.11 (d, 6.9)
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Table. 2.29: NMR data of compound 24
13C 1H HMBC
1 177.8
2 40.5 2.52 (q, 6.9)
3 42.6 2.28 (dd, 15.3, 6.9) C1, C2, C4, C5, C35
2.18 (dd, 15.3, 6.9) C4
4 134.0
5 130.5 3.86 (d, 5.3) C5 (direct)C3, C8, C35
6 30.5 1.62 (m)
7 44.1 1.62 (m) C5, C6, C8, C33, C34
1.17 (m) C5, C6, C8, C33, C34
8 71.6 4.85 (HDO peak) C9
9 172.2
10 41.9 2.94 (dd, 16.1, 7.9) C10 (direct), C9, C11, C26 
2.74 (dd, 16.1, 6.3) C10 (direct), C9, C11, C26 
11 50.4 5.09 (dd, 12.0, 5.7) C10, C26
12 170.9
13 56.9 5.59 (dd, 10.0, 6.3) C12, C14, C16, C18, C19 
14 174.9
15 46.9 4.40 (q, 6.6) C1, C14, C17
16 18.1 0.79 (d, 6.9) C16 (direct), C13, C14, 
17 31.7 3.12 (s) C17, C14, C15
18 25.1 3.30 (MeOD peak) C12, C13, C21, C26 
3.10 (m) C12, C13, C21, C26 
19 110.5
20 129.0
21 111.6 7.50 (d, 8.2) C19, C20, C23, C25 
22 120.5 7.06 (t, 8.2) C22 (direct), C20, C21
23 122.9 6.98 (m) C23 (direct), C21, C25
24 119.2 7.50 (d, 8.2) C24 (direct), C20, C22
25 138.0
26 110.1
27 132.7
28 128.6 6.98 (d, 8.5) C28 (direct), C11, C30, C32 
29 116.2 6.67 (d, 8.5) C29 (direct), C27, C30, C31 
30 157.7
  31 116.2 6.67 (d, 8.5) C31 (direct), C27, C29, C30, C  
32 128.2 6.98 (d, 8.5) C32 (direct), C11, C28, C30
33 19.6 1.06 (d, 7.9) C7, C8
34 22.0 0.82 (d, 6.6) C5, C6, C7
35 18.4 5.04 (s) C4, C5
4.94 (s)
36 20.0 1.11 (d, 6.9) C1, C2
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Fig. 2.79: Key HMBC correlation found for compound 26
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Table 2.30: NMR data of compound 26
13C 1H HMBC
1 178.9
2 40.5 2.52 (dd, 14.1, 6.9) C1, C36
3 37.4 2.28 (dd, 14.5, 6.8) C1, C2, C4, C35, C36
2.18 (dd, 15.3, 6.8) C1, C2, C4, C5, C35
4 150.0
5 79.0 3.86 (d, 5.33 ) C5 (direct), C4, C6, C35
6 33.5 1.62 (m)
7 42.5 1.62 (m)
1.17 (m)
8 71.5 4.85 (HDO peak)
9 172.3
10 41.5 2.94 (dd, 7.9, 16.1) C9, C11  
2.74 (dd, 16.2, 6.3) C9, C11, C27 
11 51.1 5.0 (m) C9, C10, C27, C28, C32 
12 171.4
13 57.7 5.65 (dd, 10.0, 6.3) C13 (direct), C12, C17 
14 176.5
15 47.0 4.40 (dd, 13.7, 7.0) C15 (direct), C14
16 16.6 0.79 (d, 6.9) C16 (direct), C13, C14, C15 
17 32.7 3.12 (s) C17(direct), C13, C14, C15 
18 24.7 3.30 (MeOD peak) C12, C13, C20, C26
3.10 (m) C12, C13, C20, C26
19 -
20 128.7
21 119.1 7.50 (d, 8.2) C21 (direct), C23, C25, 
22 121.1 6.96 (t, 8.0) C22 (direct), C20, C24
23 122.9 7.06 (t, 8.0) C23 (direct), C21, C25
24 111.7 7.24 (dd, 8.1) C24 (direct), C20, C22 
25 138.1
26 110.6
27 133.0
28 128.7 6.98 (d, 8.5) C28 (direct), C11, C30, C32
29 116.3 6.67 (d, 8.5) C29 (direct), C27,C31, C30
30 156.8
  31 116.3 6.67 (d, 8.5) C31 (direct), C27, C29, C30
32 128.7 6.98 (d, 8.5) C32 (direct), C11, C28, C29
33 21.3 1.06 (d, 7.9) C33 (direct), C8, C7
34 14.7 0.82 (d, 6.6) C34 (direct), C5, C6, C7
35 113.3 5.05 (s) C35 (direct), C3, C5
4.95 (s) C35 (direct), C3, C5
36 18.5 1.11 (d, 6.9) C36 (direct), C1, C2, C3 
Bioactivity
Jaspamide has been reported to possess remarkable biological activities such as
antifungal and antiproliferative activities [Zabriskie et al., 1986]. In particular, it
showed anthelminthic, cytotoxic, selective antimicrobial, insecticidal, and
ichthytotoxic activities [Zabriskie et al., 1986; Crews et al., 1986; Braekman et al.,
1987].
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Jaspamide B and C were also reported to exhibit cytotoxicity against the human
NSCLC-N6 cancer cell line with IC50 values of 3.3 and 1.1 µg/mL, respectively
[Zampella et al., 1999].
Compound 24 exhibited activities in all biotests. In the brine-shrimp lethality test, it
gave a 100% mortality rate at 100 ppm. When tested against S.littoralis, jaspamide
showed strong insecticidal activity causing 100% mortality rate at 50 ppm. When
tested for antimicrobial activity, jaspamide showed strong activity against Candida
albicans but exhibited no activity against gram-positive and gram-negative test
organisms (Table 2.31). Compound 24 also showed activities against human
leukemia cell lines (Table 2.32).
Table 2.31: Agar plate diffusion assay of compound 24
Zone of Inhibition (mm)Concentration
(µg/disk) S. aureus E. coli B. subtilis C. albicans
1 n.a. n.a. n.a. 7
5 n.a. n.a. n.a. 20
10 n.a. n.a. n.a. 20
50 n.a. n.a. n.a. 28
Table 2.32: Cytotoxicity test for compound 24
Growth rates (%) of different
cell linesConcentration(µg/mL)
JURKAT THP-1
0.1 56 56
1 22 11
2.5 - 8
5 - 5
10 10 2
20 4 -
25 - 2
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3. Materials and Methods
3.1. Biological materials
Samples include sponges and sponge-associated fungi collected in Indonesia, the
Philippines and Italy. The sponges were collected by scuba diving and voucher
specimen were identified by Dr. Rob W. M. van Soest of the Zoological Museum,
Amsterdam. For the isolation of fungi, the scheme illustrated in Fig.3.1 was used, a
piece of the inner part of the sponge was cut under sterile conditions, and inoculated
on agar slants and incubated at 27oC. A pure culture of the fungi was prepared
through repeated inoculation on fresh malt agar plates. The fungi were then grown in
300 mL cultures and after a period of incubation, both the mycelium and broth were
extracted. The extracts were screened for biological activity and those exhibiting
significant bioactivity were mass cultivated under the same growth conditions. A
sample culture of the fungi were sent to the Centraalbureau voor Schimmelcultures
(CBS), Baarn, Netherlands or to the  Alfred-Wegener-Institut für Polar- und
Meeresforschung for identification. 
Small scale cultivation of fungal isolate (300mL)
Isolation of pure fungi species
Upscale Cultivation of bioactive fungi
Bioassay of extracts of cultured fungal isolates
Extraction
(10L)
Fig. 3.1: Fungal collection, isolation, and cultivation scheme
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3.1.1. Sponge-derived fungi
The isolated fungi were grown on agar plates using the GPNS medium developed by
Schaumann. For eliminating bacterial contaminants Chloramphenicol – 0.2 g/l;
Streptomycine Sulfate – 0.1 g/l; Penicillin G- 0.1 g/l were added.
Glucose-Monohydrate 1.0 g
Peptone (aus Casein/merck) 0.5 g
Yeast Extract (Merck) 1.0 g
Ammonium nitrate 1.0 g
Agar (Merck) 16.0 g
Sea water  (ca. 30% sea salt) 1000 ml 
pH (NaOH/HCl) 7.2-7.4
After purification, the fungi is grown on 300 mL medium in a 1 L flask and grown for
approximately one month. The fungi is then screened for bioactivity (brine-shrimp,
insecticidal, antimicrobial, cytotoxic). After the optimum growth time, the culture is
added with Ethylacetate and allowed to stand overnight. The broth and mycelium are
then extracted exhaustively with ethyl acetate. 
Bioactive fungi are then re-grown in 10 L medium under the same culture condition
as the bioscreening culture. 
3.1.1.1. Cladosporium herbarum
Samples of the sponge Callyspongia aerizusa were collected near Bali Barat
National Park in Indonesia. The fungus was grown on malt agar slants consisting of
15 g/l agar, and 24.4 g/l artificial sea-salt mixture. The isolated fungus was identified
as Cladosporium herbarum by the Centraalbureau voor Schimmelcultures (CBS),
Baarn, Netherlands. Mass cultivation of the fungus was carried out in erlenmeyer
flasks in malt extract broth consisting of 1.5% malt extract in distilled water
supplemented with 2.44% of SERA artificial sea salt mixture at pH 7.6 – 7.8. After 41
days incubation at room temperature without shaking, the fungal biomass was
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separated from the culture broth, and both the mycelium and the broth were
extracted with ethyl acetate.
3.1.1.2. Curvularia lunata
Samples of the sponge Niphates olemda (De Laubenfels, 1954) were collected by
scuba diving in Bali Barat National Park in Indonesia. A voucher fragment is kept in
70% methanol under the registration number ZMA POR. 13438 in the Zoological
Museum, Amsterdam. The isolated fungus was identified as curvularia lunata by the
Centraalbureau voor Schimmelcultures (CBS), Baarn, Netherlands.  Mass cultivation
of the fungus was carried out in Erlenmeyer flasks in malt extract broth consisting of
1.5% malt extract in distilled water supplemented with 2.44% of SERA artificial sea
salt mixture at pH 7.6 – 7.8. After 32 days of incubation at room temperature without
shaking, the fungal biomass was separated from the culture broth, and both the
mycelium and the broth were extracted with ethyl acetate.
3.1.1.4. Pennicillium spp. and an unidentified fungus
 
From the sponge Axinella verrucosa collected in Secca di Corallo, Elba, Italy was
isolated twenty-two fungi species which have been grown in 1L-Erlenmeyer flasks
containing 300 mL culture broths of the Wickerham medium which consists of yeast
extract (3 g/L), maltextract (3 g/L), peptone (5 g/L), glucose (10 g/L), sea salt (24.4
g/L).The pH of the medium was adjusted to 7.2 – 7.4 using NaOH and HCl. After 21
days at room temperature, the culture broths were added with 300 mL EtOAc,
transferred in polyethylene and cooled under –86o C until they are transported per
courier under dry ice to the University of Düsseldorf. The ethyl acetate extracts of the
fungi were subjected to preliminary bioactivity screening. 
3.1.1.5. Aspergillus flavus
Samples of the demosponge Hyrtios aff. reticulatus (Thiele, 1898) were collected
near the island of Cabilao, Loon, Bohol in the central part of the Philippines. A
voucher sample of the sponge is kept at the Zoological Museum, Amsterdam, with
the registration number ZMA POR.16869. The fungus isolated from this sponge was
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cultivated in Wickerham medium as described for Penicillium spp. After 30 days at
room temperature, the culture broths were added with 300 mL EtOAc and left
overnight at room temperature. The ethyl acetate extracts of the fungi were subjected
to preliminary bioactivity screening.
3.1.2. Marine sponges
3.1.2.1. Agelas nakamurai
The sponge (Fig. 3.2) was collected from a depth of 44 ft. near Pulau Kapoposang in
Indonesia. It forms an irregular thick-walled flabellate mass with an irregular surface.
The skeleton is a fine-meshed reticulation of sponge fibers of which the primary ones
are cored with one to four spicules in cross section, and the connecting fivers are
uncored. All fibers are lightly echinated. The spicules are the usual verticillated
acanthostyles 180-285 x 12-20 µm with 17-26 whorls of spines. A voucher specimen
has been deposited in the Zoological Museum Amsterdam, reg. no. ZMA POR.
16735.
Fig.3.2: Agelas nakamurai
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3.1.2.2. Jaspis splendens
The sponge was collected in 1996 in Ujung Pandang, Indonesia. It was identified by
Dr. Van Soest of the Zoological Museum Amsterdam.
3.2. Chemicals used
3.2.1. General laboratory chemicals
Anisaldehyde (4-methoxybenzaldehyde) Merck
L-(+)-Ascorbic acid Merck
Glacial acetic acid Merck
Formaldehyde Merck
Gentamycin sulfate Merck
Hydrochloric acid Merck
Nipagin A (p-hydroxybenzoic acid) Sigma
Sodium hydroxide Merck
Concentrated sulfuric acid Merck
Trifluroacetic acid (TFA) Merck
3.2.2. Culture nutrient media
Agar-agar Merck
Ammonium nitrate Merck
Artificial sea salt SERA
Chloramphenicol Merck
Glucose-monohydrate Merck
Yeast Extract Merck
Penicillin G Merck
Peptone (aus casein) Merck
Streptomycine Sulfate Merck
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3.2.3. Solvents
Acetone
Acetonitrile
Chloroform
Dichloromethane
Diethylether
Dimethylsulfoxide
Ethanol
Ethyl Acetate
Hexane
Methanol
Solvents were purchased from the Institute of Chemistry, University of Wuerzburg.
They were distilled prior to use and spectral grade solvents were used for
spectroscopic measurements.
3.2.4. Chromatography:
Precoated TLC plates (AluO, Silica Gel 60 F254, Merck
layer thickness 0.2 mm
Pre-coatred TLC plates (Glass), RP-18, F254 S, Merck
layer thickness 0.25 mm
Silica Gel 60, 0.04-0.063 mm mesh size Merck
Sephadex LH 20, 25-100 mm mesh size Merck
Pre-packed LOBAR Columns Sigma
Silica Gel 60, 40-63 m, 25 mm i.d. x 310 mm
RP C18, 40-63 m, 25 mm i.d. x 310
HPLC Solvents:
Methanol LiChroSolv HPLC Merck
ortho-Phosphoric Acid 0.15%, pH 2.0 (prepared
from ortho-Phosphoric Acid 85% p.a.) Merck
Nanopure Water Barnstead
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3.3 Equipments used
Balances Mettler AT 200
Mettler AT 250
Mettler PE 1600
Sartorius RC210P
Centrifuge TGA-Ultracentrifuge, Rotor 65.13;
Konton
Fraction collector ISCO Cygnet
Freeze Dryer a) Christ Alpha 2-4 with Equipment
Control; LDC-IM and Vacuum Pump
DVO 004B
b) LYOVAC GT2
Pump TRIVAC D10E
Hot plates Camag
Syringe Hamilton 1701 RSN
Mill Moulinex 354
Magnetic Stirrer Variomag Multipoint HP
Mixer Braun
PH-Electrode WTW pH 350
Rotary Evaporator Buchi Rotavap RE111; 
Buchi Rotavap R-200
Drying Ovens Heraeus T 5050
Sonicator Bandelin Sonorex RK 102
UV Lamp Camag (254 and 366 m,)
UV/Vis Spectrophotometer Perkin-Elmer Lambda 2
Vibrofix Shaker Janke & Kunkel, VF 1
Vacuum Filtration Supelco
Vacuum Exsicator Savant SpeedVac SPD111V
Savant Refrigerator Vapor Trap RVT400
Pump Savant VLP80
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HPLC equipment:
I. Gynkotek
Pump: Gynkotek, M40
HPLC Program: Gynkosoft (v.5.4)
Detector: Gynkotek, Photodiode Array Detector UVD 340
Autosampler: Gynkotek Autosampler GINA 50
Printer: NEC P60
II. Dionex
Pump: Dionex P580A LPG
HPLC Program: Chromeleon Ver 6.3
Detector: Dionex, Photodiode Array Detector UVD 340S
Column thermostat:STH 585
Autosampler: ASI-100T
3.4. Chromatographic methods
3.4.1. Thin layer chromatography
TLC were performed on precoated TLC plates with Si gel 60 F254 (layer thickness 0.2
mm, E. Merck. Darmstadt, Germany) with CH2Cl2:MeOH (90:10 or 95:5) or
CH2Cl2:iso-C3H7OH (75:25) for semi-polar compounds. TLC on Diol plates were also
used for other semi-polar compound using EtOAc:n-Hexane (70:30) or
EtOAc:Acetone (9:1). TLC on reversed phase (RP)-C18 F254 (layer thickness 0.25
mm, E. Merck, Darmstadt, Germany) was sometimes used for polar substances and
using the solvent system MeOH:H2O (85:15, 80:20, 70:30 or 60:40).
The compounds were detected from their UV absorbance at 254 and 366 nm or by
spraying the TLC plates with anisaldehyde reagent follwed by heating at 110oC.
Anisaldehyde/H2SO4 Spray Reagent (DAB 10)
Anisaldehyde: 5 parts
Glacial Acetic acid: 100 parts
Methanol: 85 parts
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Were mixed, to which 5 parts of concentrated H2SO4 were added slowly. The reagent
was stored in an amber-colored bottle and kept refrigerated until use.
TLC was used to monitor the identity of each of the fractions and the qualitative purity
of the isolated compound. It was also utilized to optimize the solvent system that
would be applied for column chromatography. 
3.4.2. Column chromatography
Crude extracts were subjected to repeated separation through column
chromatography using appropriate stationary phase and solvent system previously
determined by TLC. Further purification of fractions were later performed on
prepacked LOBAR columns.
The following separation systems were used:
a) Stationary Phase: Sephadex LH-20 (25-100 m diameter)
Solvent system: MeOH or acetone
b) Stationary Phase: RP-18 (LOBAR, size A and B)
Solvent system: MeOH : Nanopure water
c) Stationary Phase: Diol (LOBAR, size A and B)
Solvent system: EtOAc : Hexane or EtOAc : Acetone
d) Stationary Phase: Silica gel (LOBAR, size A and B)
Solvent system: CH2Cl2 : MeOH or CH2Cl2 : iso-C3H7OH
3.4.3. Semipreparative HPLC
The semipreparative HPLC was used for the isolation of pure compounds from
fractions previously separated using column chromatography. Each injection consists
of 2 mg of the fraction dissolved in 1 mL of the solvent system. The solvent system,
which is composed of MeOH and Nanopure water with 0.1% TFA, was pumped
through the column at a rate of 5 mL/min. The eluted peaks which were detected by
the online UV detector were collected separately in Erlenmeyer flasks.
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3.4.4. Analytical HPLC
Analytical HPLC was used to identify interesting peaks from extracts and fractions as
well as to evaluate the purity of isolated compounds. The gradient used started with
10:90 [MeOH: nanopure H2O (0.1% o-phosphoric acid)] to 100% MeOH in 35
minutes. Peaks are detected by UV-VIS diode array detector.
3.5. Procedure for the isolation of the secondary metabolites 
3.5.1. Isolation of the secondary metabolites from Cladosporium herbarum
Ethyl acetate 
extract
Petroleum ether 
phase (Inactive)
Ethyl acetate 
phase (Active 
against 
B.subtilis and S. 
aureus)
n-Butanol 
phase (Active 
against B. 
subtilis and S. 
aureus)
Fraction 1
active
Fraction 2
active
Fraction 3
inactive
Fraction 4
inactive
Fraction 5
inactive
Sumiki's acid
Iso-cladospolide 
B
Acetyl sumiki's 
acid
Cladospolide B Pandangolide 2
Pandangolide 3 Pandangolide 4
Solvent phase extraction
Antimicrobial Assay
RP-18
MeOH:H2O
(60:40)
RP-18
MeOH:H2O
(15:85)
RP-18
MeOH:H2O
(60:40)
RP-18
MeOH:H2O
(60:40)
Preparative 
HPLC
Preparative 
HPLC
Diol
ETOAc:n-Hex
70:30
Diol
ETOAc:n-Hex
70:30
Silica
CH2Cl2:iso -
C3H7OH (75:25)
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3.5.2. Isolation of metabolites from Curvularia lunata
Ethyl acetate 
extract
(antimicrobial)
Fraction 1
inactive
Fraction 2
active
Fraction 3
active
Sephadex, 100% Acetone
Antimicrobial Assay
(+)-Abscisic 
acid
RP-18
MeOH:H2O
(70:30)
Cytoskyrin ALunatin
Diol
ETOAc:Aceton
(90:10)
Prep HPLC
Undissolved 
residue (active)
Preparative 
HPLC
3.5.3. Isolation of metabolites from Penicillium spp.
Ethyl acetate 
extract
Sephadex, 
100% MeOH
Fraction 1 Fraction 2 Fraction 3 Fraction 4 Fraction 5
Methanol Phase
(Active)
Cyclohexane
phase
(Inactive)
Solvent phase extraction;
Bioscreening
Dechlorogriseofulvin
Griseofulvin
Oxaline Communesin B Communesin C Communesin D
Preparative 
HPLC
Preparative HPLC
Preparative 
HPLC
Silica, 
CH2Cl2:MeOH
(95:5)
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3.5.4. Isolation of monocerin from an unidentified fungus
Ethyl acetate 
extract
RP-18
MeOH:H2O (80:20)
Solvent phase 
extraction, 
Bioscreening
Cyclohexane 
phase, 
(Inactive)
Methanol phase
(active)
Monocerin
3.5.5. Isolation of α-cyclopiazonic acid from Aspergillus flavus
Ethyl acetate 
extract
RP-18
MeOH:H2O (80:20)
Solvent phase 
extraction, 
Bioscreening
Cyclohexane 
phase, 
(Inactive)
Methanol phase
(Active)
α-CPA
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3.5.6. Isolation of metabolites from Jaspis splendens
Total extract
Solvent phase 
extraction;
Bioassay
Petroleum ether 
phase
(Inactive)
Ethyl acetate 
phase (Active)
n-Butanol 
phase (Inactive)
Sephadex, 100% MeOH)
Bioassay
Fraction 1 Fraction 2 Fraction 3
(Active)
Fraction 4 Fraction 5
Silica, 
CH2Cl2:MeOH
(90:10)
Jaspamide Jaspamide B Jaspamide C
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3.5.7. Isolation of metabolites from Agelas nakamurai
Total extract
Solvent phase 
extraction;
Bioassay
Methanol phase 
(Active)
Cyclohexane 
phase (Inactive)
Sephadex, 
100% MeOH
Fraction 1 Fraction 2 Fraction 3 Fraction 4 Fraction 5 Fraction 6 Fraction 7
RP-18; 
MEOH:H2O 
(60:40) + 
0.1%TFA
4-bromo-2-
carboxylamide
4-bromo-2-
carboxylic acid
Fraction 8
Preparative HPLC
Mukanadin 
B
Debromolongamide
Preparative HPLC
3.6. Structure elucidation of the isolated secondary metabolites
3.6.1. Mass spectrometry (MS)
Low resolution MS. Low resolution mass spectra were measured by ESI-, EI-, CI-
and FAB-MS on a Finnigan MAT 8430 mass spectrometer. Measurements were
done by Dr. Ludger Witte at the Institute of Organic Chemistry, University of
Braunschweig, Dr. Albrecht Berg of Hans Knoll Institut für Naturstofforschung, Jena,
and Dr. Peter Tommes of HHU Düsseldorf.
EIMS (electron impact mass spectroscopy) analysis involves vaporizing a compound
in an evacuated chamber and then bombarding it with electrons having 25-80 eV
(2.4-7.6 MJ/mol) of energy. The high energy electron stream not only ionize an
organic molecule (requiring about 7-10 eV) but also cause extensive fragmentation
(the strongest single bonds in organic molecules have strengths of about 4 eV). The
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advantage is that fragmentation is extensive, giving rise to a pattern of fragment ions
which can help to characterize the compound. The disadvantage is the frequent
absence of a molecular ion. For standard MS/MS measurements a gradient of 10:90
[ACN : nanopure H2O (0.1% HCOOH)] to 100% Acetonitrile in 35 min was used.
ESIMS (electron spray ionization) is a method for ejecting ionized molecules from a
solution by creating a fine spray of highly charged droplets in the presence of a
strong electric field. This type of ionizaiton is highly conducive to the formation of
multiply charged molecules. 
High resolution MS.  High resolution is achieved by passing the ion beam through
an electrostatic analyser before it enters the magnetic sector. In such a double-
focusing mass spectrometer, ion masses can be measured with an accuracy of about
1 ppm. With measurement of this accuracy, the atomic composition of the molecular
ions can be determined.
LCMS. High-pressure liquid chromatography (HPLC) is a powerful method for the
separation of complex mixtures, especially when many of the components may have
similar polarities. If a mass spectrum of each component can be recorded as it elutes
from the LC column, quick characterization of the components is greatly facilitated.
Usually, ESIMS is interfaced with LC to make an effective on-line LC/MS. HPLC/ESI-
MS was carried out using a Finnigan MAT TSQ-7000 mass spectrometry connected
to a UV detector. The samples were dissolved in water/MeOH mixtures and injected
to HPLC/ESI-MS set-up. HPLC was run on a Nucleosil C-18 reversed-phase column.
Measurements were done at the Institute of Food Chemistry, University of Würzburg
and at HHU Düsseldorf.
3.6.2. Nuclear magnetic resonance spectroscopy (NMR)
NMR measurements were done by Dr. Victor Wray at the Gesellschaft für
Biotechnologiesche Forschung (GBF) in Braunschweig and by Prof. Dr. Peters at the
Institut für Organische Chemie und Makromolekulare Chemie of the Heinrich-Heine
Universität Düsseldorf. 1H and 13C NMR spectra were recorded at 300oK pm Bruker
DPX 300, ARX 400 or AVANCE DMX 600 NMR spectrometers. All 1D and 2D
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 were obtained using the standard Bruker software. This sample is dissolved
euterated solvent (i.e. DMSO-d6, CDCl3, MeOD), the choice of which is
ent on the solubility of the sample. Solvent signals at 3.30 ppm and 49.0 ppm
) and at 2.49 ppm and 39.5 ppm (DMSO-d6) were considered as internal
d (reference signal). The observed chemical shift (δ) values were given in
d die coupling constants (J) in Hz.
frared spectroscopy (IR)
 spectra were recorded at the Institut of Organic Chemistry, University of
urg on an FTIR Spektrometer Perkin-Elmer 1605 using KBr disks as
litter. About 1.0 mg of the solid compound is finely ground in a small agate
with a drop of liquid hydrocarbon, Nujol. The solid is ground with 10 to 100
s bulk of pure KBr and the mixture was pressed into a disc using a mould and
ulic press. 
D
ctrum were recorded Jobin Yvon CD 6 using methanol as solvent. CD is a
ement  of the difference in the absorbance by a chiral molecule of left and
cularly polarized light. CD curves are plots of ∆ε against the wavelength. The
s were done at the Institute of Organic Chemistry, University of Würzburg.
ptical activity
 rotation was determined on a Perkin-Elmer-241 MC Polarimeter by
ing the angle of rotation at the wavelength of 546 and 579 nm of a mercury
mp at room temperature (25oC) in a 0.5 mL cuvette with 0.1 dm length. The
 optical rotation was calculated using the expression:
[α]       =
D
20
[α]579  x 3.199
4.199
[α]579
[α]546
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where the specific rotation at the wavelength of the sodium D-line, 589
nm, at a temperature of 20oC.
[α]579 and [α]546 = the optical rotation at wavelength 579 and 546 nm respectively,
calculated using the formula:
                                                         [α]λ =   100 x α
             l x c
where α = the measured angle of rotation in degrees,
l   = the length in dm of the polarimeter tube,
c  = the concentration of the substance expressed in g/100 mL of the solution
3.7. Bioassay
The methods for the detection of biological activity of natural proudct mixtures can
best be divided into two groups for screening purposes: general screening bioassays
and specilized screening bioassays. The search for specific pharmacologic activites
often overlooks other useful activities which are not detected or are ignored, in the
screening process. Furthermore specific test methods are often cumbersome and
expensive. Hence, for bioassay-guided isolation of actives from natural product
mixtures single, inexpensive ‘bench-top’ bioassays for the rapid screening of extracts
and fractions have to be employed. Since most active plant principles are toxic at
elevated doses, a possible approach to developing an effective general bioassay
might be simply to screen for substances that are toxic to zoologic systems. Once
such substances have isolated, a battery of specific and more sophisticated
bioassays could then be employed. 
3.7.1. Brine-shrimp assay 
This technique is an in vivo lethality test in a tiny crustacean, the brine shrip (Artemia
salina Leach). It has been previously utilized in various bioassay systems including in
the analysis of pesticide residues, mycotoxins, stream pollutants, anesthetics,
dinoflagellate toxins, morphine-like compounds, toxicity of oil dispersants,
cocarcinogenicity of phorbol esters and toxicants in marine environments [Meyer et
[α]       =
D
20
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al., 1982]. This test takes into account the basic premise that pharmacology is simply
toxicology at a lower dose, and that toxic substances might indeed elicit, at a lower
non-toxic dose, interesting pharmacologic effects [McLaughlin, 1991]. The procedure
determines LC50 values in µg/ml of active compounds and extracts in the brine
medium. 
Sample preparation. The test samples were dissolved in an organic solvent and the
appropriate amount is trasferred to a 10-ml sample vial. For crude extracts, 0.5 µg of
the compound were used and various concentrations of the pure compound.The
samples were then dried under nitrogen and the dried samples were reconstituted
with 20 µL DMSO.  Control vials containing DMSO were also prepared. 
Hatching the eggs. Brine shrimp eggs (Dohse, Aquristik GmbH, Bonn, Germany)
were hatched in a small tank filled with artificial sea water which was prepared with a
commercial salt mixture (Sera Sea-Salt, Aquaristik GmbH, Bonn, Germany) and
distilled water. After 48 hours, 20 nauplii were collected by pipette (counted
macroscopically in the stem of the pipette against a lighted background) and
transferred into each test sample vial. Artificial sea water was then added to make 5
mL. The vials were maintained under illumination. Survivors were counted, with the
aid of a magnifying glass after 24 hours and the percent deaths at each dose and
control were determined. The LC50’s were determined using the probit analysis
method.
3.7.2. Insecticidal bioassay
The polyphagous pest insect Spodoptera littoralis Boisd. (Noctuidae, Lepidoptera),
commonly known as Egyptian cotton worm, has proved to be a good test model for
an insecticidal bioassay on a broad spectrum of chemical classes of natural products.
The larvae of S. littoralis feed on a wide variety of plant species and are one of the
most robust and hazardous pest insects in the Mediterraneian as well as in Africa. S.
littoralis has a short life cycle of 4 weeks and is easy to maintain in the laboratory by
utilizing an artificial diet consisting mainly of leguminous beans in agar.
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Culture conditions. Larvae of S. littoralis were from a laboratory colony reared on
artificial diet under controlled conditions [Srivastava et al., 1991]. Optimum growth
was achieved under standardized conditions at a temperature of 28oC and a
controlled day and night phase of 16 and 8 h, respectively.
Larvae at their pre-pupal stage were regularly separated (to prevent from being
cannibalized) and set on Vermiculit, a kind of silicated mineral, until they reach the
pupal stage. The pupae were then stored to a dark humid chamber at 28oC until they
develop to their final adult stage. The adults were then transferred to a  10-liter
plastic pail, lined with filter paper on which the female can lay their eggs. The adults
feed on saccharose solution at this stage, they were maintained at a controlled day
and night phase of 16 and 8 h, respectively, and at a temperature of 28oC. The laid
eggs were collected every two days and again transferred to the dark chamber until
the neonate larvae hatch.
Artificial diet. The artificial diet consisting mainly of leguminous beans in agar were
first left to stand overnight in 460 mL water and then homogenized in a mixer. To the
bean suspension, the following substances were added:
  3.0     g L-(+)- Ascorbic acid
  3.0     g Nipagin
30.0     g Baker’s Yeast
  0.180 g Gentamycin Sulfate
 1.0 mL Formaldehyde Solution
To this bean homogenate, warm agar suspension (10 g agar cooked in 315 mL water
and cooled down to 50oC) was added and thoroughly mixed. The agar bean mixture
was then poured into a 3-liter GERDA box and cooled to room temperature to
solidify. The solidified agar-bean diet was then stored in the refrigertor until use.
Chronic feeding assay. The neonate larvae of S. littoralis are forced on a diet
treated with a known concentration of a test sample, then the larvae are monitored
after 6 days. The diet consist of a freeze-dried form of the above-described bean
homogenate mixture, this time consisting only of nipagin, baker’s yeast and
formaldehyde solution. The test sample, dissolved in 2 mL carrier solvent, was
Materials and Methods
141
incorporated to 0.735 g of the freeze-dried homogenate, and the mixture is allowed to
stand overnight to allow evaporation of the carrier solvent. For biological screening
studies, concentrations of 5.0 and 1.0 mg were used for crude extracts and pure
compounds, respectively. To the treated homogenate, 2.2 mL of warm agar
suspension was added and then left to solidify at room temperature. Twenty neonate
larvae of S. littoralis were used per assay whose growth are then monitored after 6
days of incubation at 28oC in a dark humid chamber. Activity is measured as the
survivial rate or growth rate of the surviving larvae when compared to controls.
% survival rate                  =   number of surviving larvae (sample)  x 100
                                               number of surviving larvae (control)
% growth rate                    =   Average larval weight (sample) x  100
                                                Average larval weight (control)
A subsequent experiment on the active compound was analyzed for activity at a
range of doses. Potency was determined as the effective concentration (EC50) of the
test substance added to that diet necessary to cause a 50% reduction in weight.
Lethal concentration that cause 50% death (LC50) were also determined. The ED50
and LC50 were calculated by probit analysis from the dose response curve.
3.7.3. Antibacterial activity
Microorganisms.  Crude extracts and pure compounds were tested for activity
against the following standard strains: gram positive bacteria Bacillus subtilis 168 and
Staphylococcus aureus ATCC 25923, gram negative bacteria Escherichia coli ATC
25922 and Escherichia coli HB 101. The bacterial strains were from the laboratory
cultures of the Institut für Infektionsbiologie, University of Würzburg.
Culture preparation. The agar diffusion assay was performed according to the
Bauer-Kirby-Test (DIN 58940, Bauer et al. 1966). Prior to testing, a few colonies (3 to
10) of the organism to be tested were subcultured in 4 ml of tryptose-soy broth
(Sigma, FRG) and incubated for 2 to 5 h to produce a bacterial suspension of
moderate cloudiness. The suspension was diluted with sterile saline solution to a
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density visually equivalent to that of a BaSO4 standards, prepared by adding 0.5 ml
of 1% BaCL2 to 99.5 ml of 1% H2SO4 (0.36 N). The prepared bacterial broth is
inoculated onto Müller-Hinton-Agar plates (Difco, USA) and dispersed by means of
sterile beads. 
Agar diffusion assay. For screening, aliquots of the test solution were applied to
sterile filter-paper discs (5 mm diameter, Oxoid Ltd.) to give a final disc loading
concentration of 500 µg for crude extracts and various concentrations (50, 25, 10, 5
and 1µg/disk) for pure compounds. The impregnated discs were placed on agar
plates previously seeded with the selected test organisms, along with discs
containing solvent blanks. The plates were incubated at 37oC for 24 h then
antimicrobial activity was recorded as the clear zone of inhibition surrounding the disc
at which the diameter was measured in mm.
3.7.4. Cytotoxicity test
Cytotoxicity tests were carried out by Dr. Klaus Steube of DSMZ (Deutsche
Sammlung von Mikroorganismen und Zellkulturen GmBH, Braunschweig, Germany).
The tests used human leukemia cell lines U-937 [Sundstrom et al., 1976], MONO-
Mac-6 [Ziegler-Heitbrock et al., 1988], JURKAT [Schneider et al., 1977], THP-1
[Tsuchiya et al., 1980], and MM-1. 
The cells were grown in plastic flasks (Nunc, Wiesbaden, Germany). All cultures
were propagated using standardized media supplemented with 10-20% heat-
inactivated fetal bovine serum and were cultivated at 37oC in a humidified
atmosphere containing 5% CO2. 
The freeze-dried compound were dissovled in EGMME (ethylene glycol monomethyl
ether) or DMSO, diluted in RPM1-1640 culture medium and stored frozen at –20oC.
At the final dilution used in the experiments, the EGMME/DMSO concentration was
0.1%.
For the experiments, exponentially growing cells (viability of >90% as measured by
trypan blue exclusion) were harvested, washed and resuspended in fresh medium at
Materials and Methods
143
a final concentration ranging between 2 and 4 x 105 cells/mL (depending on the cell
line). Total cell number and viability were determined in a cell counting chamber after
staining the cells with trypan blue. Aliquots of 90 µL were seeded out into 96-well flat-
bottom culture plates (Nunc, Wiesbaden, Germany). Ten microliters of medium with
the solvent EGMME/DMSO or the different concentration of the test compound were
added. After a 48 h incubation/cultivation period the extent of cytotoxicity was
evaluated by the MTT assay [Steube et al, 1998] or by the Thy assay. In the latter,
cytotoxicity was determined by incorporaion of [3H]thymidine. Radioactive
incorporation was carried out for the last 3 h of the 48 h incubation period. One µCi of
[methyl-3H]-thymidine (Amersham-Buchler, Braunschweig, Germany; specific activity
0.25 mCi/µmol) was added in a 20 µL volume to each well. Cells were harvested on
glass fiber filters with a multiple automatic sample harvester, and radioactivity was
determined in a liquid scintillation counter (1209 Rackbeta, LKB, Freiburg, Germany). 
All experiments were carried out in triplicates and repeated three times. As controls,
media with 0.1% EGMME/DMSO were included in the experiments.
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4. Discussion
4.1. The isolation of known compounds and dereplication
The search for new bioactive compounds from nature using bioassay-guided
isolation has the disadvantage of having a high probability of isolating previously
known secondary metabolites. This can be minimized by a system known as
‘dereplication’ which can be performed by subjecting the extract to an early form of
detection. The taxonomy, biological and chemical profiles of the extract are
investigated. The chemical profiles are usually determined by TLC and the more
modern online HPLC-NMR or HPLC-MS analyses followed by consultation of several
databases. This, however, involves interdisciplinary cooperation (i.e., identification of
the marine organism may have to be tasked to taxonomists). This requires time,
which may not always be at the disposal of every graduate research student. Hence,
chemical investigation of an unidentified marine organism may be undertaken which
then precludes this dereplication step. It is nevertheless important to point out that
the method for choosing extracts for study utilized by our research group is not
without the application of modern instrumentation such as HPLC with diode array
detection and online HPLC-ESIMS and of up-to-date database such as Antibase
2002, Dictionary of Natural Products on CD-ROM 2002, and Marinlit.
This research work made possible the isolation of five structurally-related polyketides,
including two new twelve-membered macrolides; two furoic acid compounds
including one which has been isolated for the first time; one new phthalide; two
anthraquinones one of which is a new metabolite; the known plant hormone abscisic
acid; the known phytotoxin monocerin; the known mycotoxins oxaline and α-
cyclopiazonic acid; the antifungal griseofulvin and its dechloro derivative; the
cytotoxic alkaloid communesin B and its two new derivatives; the bromo-pyrrole
alkaloids from sponge which include the new 4-bromo-pyrrole-2-carboxylic acid, and
the known compounds: 4-bromo-pyrrole-2-carboxamide, mukanadin B and
mukanadin C; and the known depsipeptide jasplakinolide (jaspamide) and its two
known derivatives jaspamide B and C from sponge.
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4.2. Fungal metabolites as antibiotics
Antibiotics, the most important type of microbial metabolites, represent one of the
largest and most diverse groups of natural products. The inhibition of one organism
by another has been observed by early microbiologists and the term antibiotic was
then used to mean ‘a chemical substance which has the capacity for inhibiting growth
and even destroying other microorganisms in dilute solutions’ [Vandamme, 1984].
The first antibiotics isolated were detected using simple screens against common
bacteria and it was in the selection of antibacterial antibiotics that the greatest
success was achieved, although screens were also carried out for antifungal,
antimycoplasma, antispiroketal, antiprotozoal, antitumor and antiviral compounds.
The agricultural antibiotics are used as feed additives or plant protectants against
bacterial, fungal and viral infections. Others are applied as preservatives or
biochemical reagents. 
To date, several tens of thousands of metabolites have been isolated from
microorganisms. Only a very small percentage of these have antibiotic activity, and it
is probably true to say that the majority of them have no known biological activity
[Berry et al., 1993]. This does not mean that they do not have any natural role since it
has been hypothesized that such compounds may have a variety of roles such as
acting as chelating agents, hormones, pheromones, as well as  being competitive
agents in natural environments [Ibid]. It was also observed that many of them have
biological activities which are not directly related to their natural environment [Nisbet
and Porter, 1989].
4.3. Metabolites from Curvularia lunata
4.2.1. Antimicrobially-active anthraquinones
The ethyl acetate extract of the fungus Curvularia lunata exhibited strong
antimicrobial activities against B. subtilis and S. aureus during the preliminary
screening. Chemical investigation of the extract yielded the antibacterial
anthraquinones: lunatin (compound 11) and cytoskyrin A (compound 10) (Fig. 2.28).
Both anthraquinones showed selective antibacterial activity against the gram positive
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bacteria B. subtilis and S. aureus. It also appeared that cytoskyrin A, a
bisanthraquinone,  is more potent than the monomeric anthraquinone lunatin, with
the former exhibiting activity with as low as 1 µg loading amount (1.74 nmol)
compared to 5 µg (17.5 nmol) of the latter. Cytoskyrin A also showed proliferative
activity against LH-60 cell line upon prolonged incubation whereas lunatin was
inactive. This seems to point out to the importance of the dimeric structure in
bisanthraquinones for cytotoxic activity, especially when literature reports of cytotoxic
activities of similar bisanthraquinones such as luteoskyrin and  rugulosin (Fig. 2.31)
[Akuzawa et al., 1992] are also considered. 
4.2.2. Biosynthesis of bisanthraquinones
The co-isolation of the monomeric lunatin and the bisanthraquinone, cytoskyrin A,
indicates the role of monomeric anthraquinones as precursors in the biosynthesis of
bisanthraquinones. Although the exact biosynthetic pathway is still not clear, this
seem to favor the biosynthetic pathway proposed by Takeda [Takeda et al., 1973].
The co-isolation from Penicillium islandicum of a series of anthraquinonoids, which
include monomeric and dimeric anthraquinones as well as modified
bisanthraquinones, have led to their theory that bisanthraquinones have been formed
biogenetically by the base-catalyzed Michael-type intramolecular condensation of a
hypothetical intermediate, a partially hydrogenated bianthraquinone. A schematic
diagram of this proposed biosythetic pathway is shown below (Fig. 4.1) incorporating
the co-isolated anthraquinonoids catenarin, (+)-iridoskyrin, (-)-rubroskyrin and (-)-
luteoskyrin. 
However, the isolation of the partially hydrolyzed monomeric anthraquinone, 5,6-
dihyrocatenarin and 5,6,7,8-tetrahydrocatenarin from a strain of Penicillium
islandicum [Bu’Lock and Smith, 1968] provides a possible alternative pathway, which
is the dimerization of partially hydrolyzed 1,3,6,8-tetrahydroxyanthraquinone
monomers by a one-electron oxidation and condensation process to form the
bisanthraquinone [Brady et al., 2000]. 
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4.2.2. Abscisic acid
The isolation of (+)-abscisic acid (compound 9, Fig. 2.28) as the major metabolite of
C. lunata raises the question of the role of this plant hormone in marine biology. Its
presence in marine algae [Crouch and Vanstaden, 1993] suggest that abscisic acid’s
role as growth-regulating hormone in higher plants may also apply in marine flora.
However, this is the first time that abscisic acid is isolated from a marine-derived
fungus which suggests a possible similar relationship between abscisic acid-
producing plant-pathogenic fungi like Cercospora cruenta [Oritani and Yamashita,
1985], Macrophoma castaneicola [Arai et a., 1989], Cercospora rosicola [Assante et
al., 1977], Botrytis cinerea [Marumo et al., 1982], and Laminaria spp. [Schaffelke,
1995] with higher plants and between marine fungi and marine algae.
4.4. Cladosporium herbarum
4.4.1. Antimicrobial metabolites 
The second fungal extract, that of Cladosporium herbarum also exhibited selective
activity against gram positive bacteria B. subtilis and S. aureus, with the activity
limited to the ethyl acetate and the n-butanol solvent phases. Comparison of the
HPLC chromatograms of the two solvent phases showed the presence of a common
polar metabolite which was later identified as sumiki’s acid (compound 6, Fig. 2.17),
a furoic acid derivative. Also isolated in trace amounts was the acetyl congener of
sumiki’s acid (compound 7, Fig. 2.17). Both compounds showed selective
antimicrobial activities against B. subtilis and S. aureus down to a loading amount of
5 µg in the agar diffusion assay. 
The four isolated macrolides and the structurally-related γ-lactone (compounds 1-5)
(Fig. 2.1 and Fig. 2.9) exhibited no antimicrobial activities. This appears to confirm
previously drawn observations that antimicrobial activity of macrolides requires the
presence of a double bond flanked by two carbonyl carbons, which are common in
other antimicrobial agents such as patulolide A and B, pyrenophorin, pyrenolides,
vermiculine, among others (Fig. 4.2) [Rodphaya et al., 1986; Antibase, 2002].
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4.4.2. Compounds with potential phytotoxic activities
4.4.2.1. Macrolides
Cladospolide A has been reported to inhibit root growth of lettuce seedlings and
cladospolide B was found to inhibit shoot elongation of rice seedlings without causing
necrosis to the plant. 
Phytotoxins and phytotoxic fungi are of importance in natural product research
because of their potential use in the production of agrochemicals. Cladospolide B
(compound 1, Fig. 2.1), for instance, and other  metabolites exhibiting plant growth-
inhibiting activities, may be used to induce dwarfism, a very important biological
phenomenon in agriculture, because it prevents crops from lying on the ground and
produces a better harvest. Conversion of a normal plant into a dwarf is usually
brought about by chemical plant growth retardants. In many cases, dwarfing agents
act by blocking gibberellin biosynthesis; therefore these compounds are sometimes
used in biosynthetic studies of gibberellins. 
Phytotoxic fungi, on the other hand have been used as herbicides. In recent years,
spores of several fungal pathogens have been sucessfully formulated as weed
control agents known as mycoherbicides, which can be sprayed onto the target weed
in the manner of a conventional herbicide [Burge, 1993]. The advantages include low
persistence, high specificity, environmental safety and relatively low production costs.
4.4.2.2. Herbaric Acid
Also co-isolated was the new phthalide herbaric acid (compound 8, Fig. 2.22) which
was found to posses no biological activities in the screenings performed. Herbaric
acid is the 5-hydroxyl derivative of the known toxin iso-ochracinic acid previously
isolated from Alternaria kikuchiana, a parasite responsible for the black spot disease
on Japanese pears [Kameda and Namiki, 1974]. Other related phthalides possessing
phytotoxic activities include convolvulol, convolvulanic acid A and B, 4-methyl-7-
hydroxyphthalide [Antibase, 2002]. Here is another case of a marine-derived fungi
producing secondary metabolites with potential phytotoxic activities. There is, of
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course, the possiblity that these fungi are of terrestrial origin and not ‘true’ or obligate
marine fungi. However, as in Curvularia lunata, there is also the probability that this
fungus is not a sponge symbiont but could be originally associated with marine algae
with which it interacts through the production of these secondary metabolites.
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Fig.4.3: Phytotoxic phthalides previously isolated from fungi [Antibase, 2002]
4.4.5. Biosynthetic pathways for polyketides (compounds 1-7)
The similarity in the structures of the macrolides, compounds 1, 3, 4 and 5, clearly
suggests that all of them are synthesized through the same biosynthetic pathway. A
scheme for the possible synthetic pathway of cladospolide B (compound 1), iso-
cladospolide B (compound 2), is proposed below (Fig. 4.4). 
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4.4.6. Different set of metabolites isolated from two C. herbarum strains
It is interesting to note that a separate investigation of another strain of C. herbarum
which was isolated from the sponge A. aerophoba performed by another researcher
in our research team yielded mainly pyrone derivatives (Fig. 4.5) [Jadulco et al.,
2002]. Since both fungal strains were cultivated under the same conditions the
chemical differences found are likely to be caused by different fungal genotypes.
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However, the isolation of cladospolide A, B and C from two Cladosporium species,
namely, Cladosporium cladosporioides [Hirota et al., 1985a] and Cladosporium
tenuissimum [Fuji et al., 1995], suggests that these macrolides maybe metabolic
markers of this genus. 
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citreoviridin A
Fig. 4.5: Compounds isolated from Cladosporium herbarum isolated from
Aplysina aeriphoba
4.5. Fungal metabolites from the extract of Penicillium spp.
4.5.1. Metabolites as taxonomic markers 
The ethyl acetate extract of a Penicillium species yielded griseofulvin (compound 13,
Fig. 2.40) as the main metabolite together with trace amounts of dechlorogriseofulvin
(compound 14, Fig. 2.40) and oxaline (compound 12, Fig. 2.40). Griseofulvin is a
well-known antifungal. In the laboratory, it showed activity against C. albicans with a
zone of inhibiton of 15 mm by 1 µg/disk loading concentration. Dechlorogiseofulvin
did not exhibit activity against C. albicans in the screening using loading
concentration of 10 µg/disk. It has been reported has a much weaker antifungal
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activity – 125 times less active than griseofulvin [MacMillan, 1951], indicating the
importance of the chloro substituent for this action. 
The pattern of metabolites produced by a fungi can also be used as a taxonomic
marker [Dreyfuss and Chapela, 1994]. Mycotoxins produced by different strains of
Penicillium species isolated from different sources were studied. It was found out that
individual strains can be characterized by their specific profiles of N-containing
secondary metabolites and produced mycotoxins of different structural types. The
alkaloids oxaline, alpha-cyclopiazonic acid, and griseofulvin are among a series of
metabolites (along with toxins such as meleagrin, ochratoxin A, citreoviridin,
roquefortin, among others) which are produced in peculiar combinations, the
production of which can identify a certain fungal taxon or a series of taxa along with
morphological and physiological data. Penicillium coprophilum, for instance is known
to produce griseofulvin, dechlorogriseofulvin, roquefortine C, meleagrin, and oxaline
[Frisvad and Filtenborg, 1990]. Thus, the taxonomic identity of a strain can indicate
the presence of the corresponding marker metabolite; alternatively, a single
metabolite or metabolite pattern frequently can point to a specific fungal taxon or
series of taxa.
4.5.2. Communesins 
Also isolated was communesin B (compound 15, Fig. 2.40) and trace amounts of two
derivatives, communesins C (compound 16, Fig. 2.40) and D (compound 17, Fig.
2.40). Communesin B exhibited potent toxicities in the brine-shrimp lethality test,
insecticidal, antimicrobial and cytotoxicity tests.  When the brine-shrimp lethality
activities of the three derivatives were compared, it was found out that communesin
C was the least active with an LC50  of 1.93 µg/mL, suggesting the importance of the
N-15-substituent. Communesin B, which has a methyl group at N-15, was the most
active with an LC50  of 0.3 µg/mL, whereas communesin D which a formyl group at N-
15 has an LC50  of 0.57 µg/mL.
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4.6. Metabolite from Aspergillus flavus and an unidentified fungus
Monocerin (compound 18, Fig. 2.59) which was isolated from an unidentified fungus
has been reported to possess phytotoxic activities and insecticidal activities. Against
S. littoralis, it exhibited strong antifeedant activity ED50 of 14.78 ppm. It also showed
antimicrobial activities against Gram-positive and Gram-negative bacteria. However,
it did not exhibit toxicity against A. salina. Likewise, α−cyclopiazonic acid (compound
19, Fig. 2.62), a well-known toxin, which was isolated from Aspergillus flavus also
exhibited antimicrobial activity and strong antifeedant activity against S. littoralis, but
had no activity against A. salina. Since both are expected to exhibit general toxicities,
their inactivity against brine-shrimp may have something to do with their poor
solubility in polar solvents where the assay is based.
The identification of cyclopiazonic acid  is of particular importance because of its
effect in human health. Normally produced by Aspergillus flavus, Penicillium
cyclopium, P. camemberti, P. commune, and P. griseofulvum and a common
contaminant of agricultural products, it has been associated with human toxicosis
commonly known as ‘kodua poisoning,’ a nonlethal illness characterized in humans
by fatigue, tremors, slurring of speech, and nausea [Abramson, 1997]. It has been
shown to be carried over from chicken feed into the muscle tissue of chicken, thus
posing a risk of contaminating human diet by chicken meat containing this toxin. 
4.7. Metabolites from sponges
4.7.1. Relationship between structure and antimicrobial activities of isolated
bromopyrrole derivatives from Agelas nakamurai 
The ethyl acetate of A. nakamurai showed strong antimicrobial activities against B.
subtilis, S. aureus, E. coli and C. albicans. Chemical investigation of the extract
yielded the antimicrobially active bromo-pyrrole alkaloids: 4-bromopyrrole-2-
carboxamide (compound 20, Fig. 2.64b) and its new acid derivative 4-bromopyrrole-
2-carboxylic acid (compound 21, Fig. 2.64b), and the known metabolites mukanadin
B (compound 22, Fig. 2.64b) and C (compound 23, Fig. 2.64b). It has been
established that these brominated compounds which are produced by sponges in
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Agelas [Urban et al., 1999], Axinella [Walker et al., 1981], Hymedinacidon [Kobayashi
et al., 1997], Stylotella [Kato et al., 1995], and Pseudoceratina [Tsukamoto et al.,
1996a] serve as chemical defense for the sponges against the attack of fishes
[Wilson et al., 1999; Lindel et al., 2000]. Bromopyrrole derivatives have also shown a
variety of biological activities including antimicrobial (Urban et al, 1999; Walker et al.,
1981), tyrosine kinase inhibitory (Kobayashi et al., 1997), and antifouling (Kato, et al.,
1995; Tsukamoto et al., 1996b) activities. 
Compounds 20, 21, and 23 showed antimicrobial activities against Gram-positive and
Gram-negative bacteria. This observation, when considered with a literature survey
of bromopyrrole alkaloids isolated from sponge (Table 4.1), appears to prove that a
bromo substituent at C-4 and an amide, carboxyl or a cyano  group are required for
antimicrobial activity. When the amide is substituted, the antimicrobial activity seem
to disappear as in compound 22 (entry 3 in Table 4.1), or to became selective as in
compound 23 (entry 2 in Table 4.1). When a second bromo group is present at C-5,
activity seems to be retained when an amide group is present at C-2 as in longamide
(entry 8 in Table 4.1) and the antimicrobially active compound sceptrin (Fig. 2.64a).
Entries 8 and 9 in Table 4.1 which both possess two bromine atoms and a carboxyl
and cyano groups at C-2, respectively, were antimicrobially inactive. When the bromo
substituent is only at C-5, activity was seen to disappear or to be more selective, as
exemplified by compounds 7 and 6 in Table 4.1, respectively. 
4.7.2. Relationship between structure and cytotoxic activities of jaspamide and
its derivatives
The sponge Jaspis splendens yielded the peptides jaspamide (jasplakinolide),
jaspamide B and jaspamide C. Jaspamide is well known for its antiproliferative
activity. A literature report comparing the cytotoxic activities of the three jaspamide
derivatives against human NSCLC-N6 cancer cell line found jaspamide B and C to
possess slightly lower activities with IC50 values of 3.3 and 1.1 µg/mL, respectively,
compared to an IC50 value of 0.36 µg/mL for jaspamide (Zampella, et al, 1999). Since
there is no drastic change in the core structure of the molecule, this difference might
be due to the decreased polarity of jaspamide which might allow it greater
permeability through cell membranes as its more polar congeners.
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Table 4.1. Biological activites of known bromopyrrole derivatives.
R1 R2 R3 Source Activity Reference
1. COOH Br H A. nakamurai Antimicrobial activity against Gram positive and Gram negative bacteria present
work
2. CONH-R4 Br H A. nakamurai Antimicrobial activity against Gram positive bacteria present
work
3. CONH-R5 Br H A. nakamurai No antimicrobial activity present
work
4. CONH2 Br H A. nakamurai Antimicrobial activity against Gram positive bacteria and Gram negative
bacteria
present
work
5. CONH2 Br H Acanthella carteri Cytotoxic against NSCLC-N6 human non-small-cell-lung carcinoma (IC50
4.8 µg/mL)
Mancini et al.,
1997
6. CONH2 H Br A. nakamurai Antimicrobial activity against Gram positive bacteria and fungi Iwagawa, et
al., 1998
7. CONH(CH2OMe) H Br A. nakamurai no antimicrobial and cytotoxic activities Iwagawa, et
al., 1998
8. CONH-R4 Br Br Agelas longissima Moderate antimicrobial activity Cafieri et al.,
1995]
9. CN Br Br Agelas oroides Moderate cytotoxicity; no antimicrobial, antifungal, algicidal, antimalarial
activities
König, et al.,
1995]
10. COOH Br Br A.oroides  
A. sventres 
No cytotoxic, antimicrobial, antifungal, algicidal, antimalarial activites 
Antifeedant against Thalassoma bifasciatum at a min conc of 0.8 mg/ml 
[König, et al.,
1995];
[Assman, et
al., 2001]
11. COOCH3 Br Br Agelas oroides No antimicrobial and cytotoxic activities König, et al.,
1995
12. CONH2 Br Br A.oroides 
A.mauritiana 
Antifouling activity against the ascidian Ciona savignyi at a conc of 2.5
µg/mL) 
Cytotoxic against NSCLC-N6 human non-small-cell-lung carcinoma (IC50
9.4 µg/mL) 
[Tsukamoto et
al., 1996b];
[Mancini et
al., 1997]
R4 = fused ring of mukanadin C (compound 23, Fig. 2.64b); R5 = aliphatic chain of mukanakin B (compound 22, Fig. 2.64b)
N
H
R 2
R 1R 3
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5. Summary
Low-molecular mass natural products from bacteria, fungi, plants and marine
organisms exhibit unique structural diversity which are of interest for the identification
of new lead structures for medicinals and agrochemicals. In the search for bioactive
compounds from marine sponges and sponge-associated fungi, this research work
resulted to the isolation of twenty-six compounds, eight of which are new metabolites.
The sponges were collected from the Indo-pacific regions, particularly those from
Indonesian and Philippine waters, as well as those from the Mediterranean Sea near
the island of Elba in Italy. A combination of the chemically- and biologically-driven
approach for drug discovery was employed, wherein extracts were screened for
antibacterial, antifungal and cytotoxic activities. In addition to the bioassay-guided
approach to purify the compounds responsible for the activity of the extract, TLC, UV
and MS were also used to isolate the chemically most interesting substances. Hence,
purified compounds which are not responsible for the initial bioscreening activity may
have a chance to be evaluated for other bioactivities. 
Enumerated below are the compounds which have been isolated and structurally
elucidated and whose bioactivities have been further characterized.
1. The extract of the fungus Cladosporium herbarum associated with the sponge
Callyspongia aerizusa afforded seven structurally related polyketides, including
two new twelve-membered macrolides: pandangolide 3 and 4, and a new acetyl
congener of the previously isolated 5-hydroxymethyl-2-furoic acid. The two furoic
acid analogues isolated were found to be responsible for the antimicrobial activity
of the extract. The isolation of the known phytotoxin Cladospolide B from
Cladosporium herbarum, which was originally known from Cladosporium
cladosporioides and C. tenuissimum, indicates the possibility that Cladospolide B
may be a chemotaxonomic marker of particular Cladosporium species. 
2. The extract of the fungus Curvularia lunata associated with the Indonesian
sponge Niphates olemda yielded three compounds, namely the new
antimicrobially-active anthraquinone lunatin, the known bisanthraquinone
cytoskyrin A, and the known plant hormone abscisic acid. The co-occurrence of
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the two structurally-related anthraquinones suggests that the monomeric lunatin
may be a precursor in the biosynthesis of the bisanthraquinone cytoskyrin A. 
3. The fungus Penicillium spp. associated with the Mediterranean sponge Axinella
verrucosa yielded six compounds, namely the known antifungal griseofulvin and
its less active dechloro analogue; the known toxin oxaline; and the known
cytotoxic metabolite communesin B and its two new congeners communesin C
and D. The new communesins were less active than communesin B in the brine-
shrimp lethality test. 
4. An unidentified fungus which was also isolated from the same Mediterranean
sponge Axinella verrucosa as Penicillium spp. yielded the known compound
monocerin which has been reported to possess phytotoxic and insecticidal
activities.
5. The fungus Aspergillus flavus associated with the Philippine sponge Hyrtios aff.
reticulatus yielded the known toxin α-cyclopiazonic acid.
6. The Indonesian sponge Agelas nakamurai yielded four bromopyrrole alkaloids
namely the new compound 4-bromo-pyrrole-2-carboxylic acid, and the known
compounds: 4-bromo-pyrrole-2-carboxamide, mukanadin B and mukanadin C. All
of the four compounds except mukanadin B were found to be antimicrobially-
active. Bromopyrrole alkaloids are well-known metabolites of the genus Agelas
and are proven to play an important role in the chemical defense of the sponge
against predation from fishes.
7. The Indonesian sponge Jaspis splendens yielded three known substances which
are known for their antiproliferative activities, namely the depsipeptides jaspamide
(jasplakinolide), and its derivatives jaspamide B and jaspamide C. 
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List of Abbreviations
[α]D : specific rotation at the soldium D-line
BuOH : butanol
br : broad signal
CD : circular dichroism
CI : chemical ionization
COSY : correlation spectroscopy
d : doublett
dd : double doublett
ddd : double double doublett
DEPT : distortionless enhancement by polarization transfer
DMSO : dimethylsulfoxide
DNA : deoxyribonucleic acid
ED : effective dose
EI : electron impact
ESI : electron spray ionization
EtOAc : ethyl acetate
eV : electronvolt
Fig : Figure
g : gram
h : hour
HMBC : heteronuclear multiple bond connectivity
HMQC : heteronuclear multiple quantum coherence
HPLC : high performace liquid chromatography
Hz : herz
IR : infrared spectroscopy
LC : lethal concentration
lit. : literature
m : multiplett
MeOD : deuterated methanol
MeOH : methanol
mg : milligram
mL : milliliter
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µg : microgram
µL : microliter
mRNA : messenger-RNA
MS : mass spectrometry
m/z : mass per charge
n.a : no activity
ng : nanogram
nm : nanometer
NMR : nuclear magnetic resonance
NOE : nuclear Overhauser effect
ppm : parts per million
q : quartett
RNA : ribonucleic acid
RP-18 : reversed phase C-18
s : singlett
t : triplett
TFA : trifluoroacetic acid
TLC : thin layedr chromatography
UV : ultra-violet
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